UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
PYXIS CORPORATION
(Name of Issuer)
COMMON STOCK, $0.01 PAR VALUE
(Title of Class of Securities)
747251106
(CUSIP Number)
ROBERT D. WALTER
CHAIRMAN
CARDINAL HEALTH, INC.
5555 GLENDON COURT
DUBLIN, OHIO 43016
(614) 717-5000
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
FEBRUARY 7, 1996
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on
Schedule 13G to report the acquisition which is the subject
of this Schedule 13D, and is filing this schedule because of
Rule 13d-1(b)(3) or (4), check the following box / /.
Check the following box if a fee is being paid with the
statement /x/.
Page 1 of 11<PAGE>
CUSIP NO. 747251106
SCHEDULE 13D
1. NAME OF REPORTING PERSON
SS OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Cardinal Health, Inc.
31-0958666
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / /
(b) / /
3. SEC USE ONLY
4. SOURCE OF FUNDS
WC
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) / /
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Ohio
NUMBER OF 7. SOLE VOTING POWER
SHARES 0
BENEFICIALLY
OWNED BY 8. SHARED VOTING POWER
EACH 0
REPORTING
PERSON 9. SOLE DISPOSITIVE POWER
WITH 0
10. SHARED DISPOSITIVE POWER
0
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,275,861 shares of Common Stock.
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES / /
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 16.6%.
Based upon 36,562,117 shares of Common Stock outstanding as
of February 5, 1996, as represented by Issuer, calculated
pursuant to Rule 13d-3(d)(1).
14. TYPE OF REPORTING PERSON
HC, CO
Page 2 of 11<PAGE>
CUSIP NO. 747251106
Item 1. Security and Issuer.
This Schedule 13D relates to the common stock, $0.01 par
value per share ("Pyxis Common Stock"), of Pyxis Corporation
("Pyxis"), a Delaware corporation. The principal executive
offices of Pyxis are located at 9380 Carroll Park Drive, San
Diego, California 92121.
Item 2. Identity and Background.
This Schedule 13D is filed by Cardinal Health, Inc.
("Cardinal"), an Ohio corporation. Cardinal is a national, full-
service wholesaler distributing a broad line of pharmaceuticals,
surgical and hospital supplies, therapeutic plasma and other
specialty pharmaceutical products, health and beauty care
products, and other items typically sold by hospitals, retail drug
stores, and other health care providers. Cardinal's principal
executive offices are located at 5555 Glendon Court, Dublin, Ohio
43016.
Each executive officer and each director of Cardinal is
a citizen of the United States. The name, business address and
present principal occupation of each executive officer and
director are set forth in Annex I to this Schedule 13D which is
incorporated herein by this reference.
During the last five years, to the best of Cardinal's
knowledge, neither Cardinal nor any of its executive officers or
directors has been convicted in a criminal proceeding (excluding
traffic violations or similar misdemeanors) or has been a party to
a civil proceeding of a judicial or administrative body of
competent jurisdiction as a result of which Cardinal or such
person was or is subject to a judgment, decree or final order
enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws, or
finding any violation with respect to such laws, and which
judgment, decree or final order was not subsequently vacated.
Item 3. Source and Amount of Funds or Other Consideration.
Pursuant to the Stock Option Agreement, dated February
7, 1996, between Cardinal and Pyxis (the "Stock Option
Agreement"), Pyxis granted Cardinal an irrevocable option (the
"Option") to purchase from Pyxis, under certain circumstances and
subject to certain adjustments, up to 7,275,861 authorized and
unissued shares of Pyxis Common Stock, at a price per share,
payable in cash, equal to the lower of (x) $24.80 or (y) the
exchange ratio under the Agreement and Plan of Merger, dated
February 7, 1996, among Cardinal, Aztec Merger Corp., a Delaware
corporation and a wholly owned subsidiary of Cardinal ("Subcorp"),
and Pyxis (the "Merger Agreement"), described under Item 4 below,
multiplied by the closing price of common shares, without par
value ("Cardinal Common Shares"), of Cardinal as reported on the
New York Stock Exchange Composite Tape on the last trading day
Page 3 of 11<PAGE>
CUSIP NO. 747251106
immediately preceding the date of delivery to Pyxis of written
notice of Cardinal's exercise of the Option. As of the date
hereof, the Option is not exercisable. The shares of Pyxis Common
Stock subject to the Option would equal 19.9% of the outstanding
Pyxis Common Stock before giving effect to the exercise of the
Option. Under certain circumstances, Cardinal may require Pyxis
to, or Pyxis may be permitted to, repurchase for cash the Option
and any shares of Pyxis Common Stock acquired pursuant to the
exercise of the Option.
The Option was granted by Pyxis as a condition of and in
consideration for Cardinal entering into the Merger Agreement.
The exercise of the Option for the full number of shares
currently covered thereby would require aggregate funds of
$170,088,003, based on an exchange ratio of .406557 and a closing
price for Cardinal Common Share of $57.50 on February 9, 1996. It
is anticipated that, should the Option become exercisable and
should Cardinal determine to exercise the Option, Cardinal would
obtain the funds for purchase from working capital or by borrowing
from parties whose identity is not yet known.
A copy of the Stock Option Agreement is included as
Exhibit 2.2 to this Schedule 13D and is incorporated herein by
this reference. The foregoing description of the Stock Option
Agreement is qualified in its entirety by reference to such
exhibit.
Item 4. Purpose of Transaction.
In connection with the execution of the Stock Option
Agreement, Cardinal and Pyxis entered into the Merger Agreement,
pursuant to which, among other matters and subject to the terms
and conditions set forth in the Merger Agreement, Subcorp will
merge (the "Merger") with and into Pyxis. The Option was granted
by Pyxis as a condition of and in consideration for Cardinal
entering into the Merger Agreement. Consummation of the Merger is
subject to certain conditions, including: (i) receipt of the
approval of the Merger Agreement by the holders of a majority of
the outstanding shares of Pyxis Common Stock; (ii) receipt of the
approval of issuance of the Cardinal Common Shares to be issued in
the Merger and of the transactions contemplated by the Merger
Agreement by the holders of a majority of the outstanding Common
Shares; (iii) expiration or termination of all waiting periods
applicable to the consummation of the Merger under the Hart-Scott-
Rodino Antitrust Improvements Act of 1976, as amended; (iv)
registration of the Cardinal Common Shares to be issued in the
Merger under the Securities Act of 1933, as amended; (v) receipt
of an opinion of counsel as to the tax-free nature of certain
aspects of the Merger; (vi) receipt of an accountant's letter
confirming that the Merger will qualify as a pooling of interests
transaction for financial reporting purposes; and (vii)
satisfaction of certain other conditions. Pursuant to the Merger
Agreement, (a) the officers of the surviving corporation in the
Page 4 of 11<PAGE>
CUSIP NO. 747251106
Merger will be the officers of Pyxis, (b) the directors of the
surviving corporation in the Merger will be the directors of
Subcorp, (c) each share of Pyxis Common Stock will be converted
into .406557 of a Cardinal Common Share, subject to adjustment
under the circumstances described in the Merger Agreement, plus
cash in lieu of fractional shares, and (d) at the effective time
of the Merger, the Certificate of Incorporation and By-laws of
Pyxis, as the surviving corporation, will be amended to be
identical (save for the name of the corporation) to those of
Subcorp. Upon consummation of the Merger, the Pyxis Common Stock
will be delisted from the Nasdaq National Market.
A copy of the Merger Agreement is included as Exhibit
2.1 to this Schedule 13D and is incorporated herein by this
reference. The foregoing description of the Merger Agreement is
qualified in its entirety by reference to such exhibit.
Except as set forth herein, Cardinal does not have any
current plans or proposals that relate to or would result in (i)
the acquisition by any person of additional shares of Pyxis Common
Stock or the disposition of shares of Pyxis Common Stock; (ii) an
extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving Pyxis or any of its
subsidiaries; (iii) a sale or transfer of any material amount of
assets of Pyxis or any of its subsidiaries; (iv) any change in the
present board of directors or management of Pyxis, including any
plans or proposals to change the number or term of directors or to
fill any vacancies on the board; (v) any material change in the
present capitalization or dividend policy of Pyxis; (vi) any other
material change in Pyxis's business or corporate structure; (vii)
any change in Pyxis's charter or bylaws, or instruments
corresponding thereto, or other actions that may impede the
acquisition of control of Pyxis by any person; (viii) causing a
class of securities of Pyxis to be delisted from a national
securities exchange or to cease to be authorized to be quoted in
an inter-dealer quotation system of a registered national
securities association; (ix) a class of equity securities of Pyxis
becoming eligible for termination of registration pursuant to
Section 12(g)(4) of the Securities Exchange Act of 1934, as
amended; or (x) any action similar to any of those enumerated
above.
Item 5. Interest in Securities of Issuer.
Although the Option does not allow Cardinal to purchase
any shares of Pyxis Common Stock pursuant thereto unless and until
the conditions to exercise specified in the Stock Option Agreement
occur, assuming for purposes of this Item 5 that such conditions
are satisfied and Cardinal is entitled to purchase shares of Pyxis
Common Stock pursuant to the Option, Cardinal would be entitled to
purchase 7,275,861 shares of Pyxis Common Stock, or approximately
16.6% of the outstanding Pyxis Common Stock after giving effect to
the exercise of the Option.
Page 5 of 11<PAGE>
CUSIP NO. 747251106
Cardinal does not currently have the right to acquire
any shares of Pyxis Common Stock under the Option unless certain
events specified in the Stock Option Agreement occur.
Accordingly, Cardinal does not have sole or shared voting or
dispositive power with respect to any shares of Pyxis Common
Stock, and Cardinal disclaims beneficial ownership of Pyxis Common
Stock subject to the Option until such events occur. Assuming for
purposes of this Item 5 that events occurred that would enable
Cardinal to exercise the Option and Cardinal exercised the Option,
Cardinal would have sole voting power and sole dispositive power
with respect to the shares acquired pursuant to the Option,
subject to Pyxis's right to repurchase such shares as set forth in
the Stock Option Agreement.
The foregoing description of certain terms of the Stock
Option Agreement is qualified in its entirety by reference to the
Stock Option Agreement which is filed as Exhibit 2.2 hereto and
which is incorporated herein by this reference.
To the best of Cardinal's knowledge, no executive
officer or director of Cardinal beneficially owns any shares of
Pyxis Common Stock, nor (except for the issuance of the Option)
have any transactions in Pyxis Common Stock been effected during
the past 60 days by Cardinal or, to the best knowledge of
Cardinal, by any executive officer or director of Cardinal. In
addition, no other person is known by Cardinal to have the right
to receive or the power to direct the receipt of dividends from,
or the proceeds from the sale of, the securities covered by this
Schedule 13D.
Item 6. Contracts, Arrangements, Understandings or
Relationships with Respect to Securities of
the Issuer.
Each of the persons set forth in Annex II to this
Schedule 13D, which Annex II is incorporated herein by this
reference, has entered into an agreement with Cardinal
pursuant to which, among other matters, such person has
agreed (i) to vote all of the shares of Pyxis Common Stock
beneficially owned by such person or its affiliates or over
which such person or any of its affiliates has voting power
or control to approve the Merger and the Merger Agreement,
(ii) not to vote such shares in favor of any other
recapitalization, merger, consolidation or other business
combination involving Pyxis, or acquisition of any capital
stock (other than upon exercise of outstanding options under
stock option plans of Pyxis in effect on February 7, 1996) or
any material portion of the assets (except for acquisitions
of assets in the ordinary course of business consistent with
past practice) of Pyxis and (iii) not to, and not to permit
any company, trust or other entity controlled by such person
to, and not to permit any of its affiliates to, contract to
sell, sell or otherwise transfer or dispose of any of such
shares or any interest therein or securities convertible
thereinto or any voting rights with respect thereto other
than pursuant to the Merger without Cardinal's consent. Such
persons in the aggregate are estimated to have
Page 6 of 11<PAGE>
CUSIP NO. 747251106
voting power over approximately 4% of the outstanding shares
of Pyxis Common Stock, based upon 36,562,117 shares of Pyxis
Common Stock outstanding as of February 5, 1996, as represented
by Pyxis. Cardinal may hereafter enter into similar agreements
with other holders of Pyxis Common Stock. A copy of the form
of Support/Voting Agreement, dated as of February 7, 1996,
executed by such persons is included as Exhibit 99.1 to this
Schedule 13D and is incorporated herein by this reference.
The foregoing description of the Support/Voting Agreement is
qualified in its entirety by reference to such exhibit.
A copy of the Merger Agreement is included as
Exhibit 2.1 to this Schedule 13D and is incorporated herein
by this reference. See Item 4.
A copy of the Stock Option Agreement is included as
Exhibit 2.2 to this Schedule 13D and is incorporated herein
by this reference. See Items 3 and 5.
Item 7. Material to be Filed as Exhibits.
The following exhibits are filed as part of this
Schedule 13D:
Exhibit 2.1 -- Merger Agreement.
Exhibit 2.2 -- Stock Option Agreement.
Exhibit 99.1 -- Form of Support/Voting Agreement.
Page 7 of 11<PAGE>
CUSIP NO. 747251106 ANNEX I
Directors and Executive Officers
Set forth below are the name and present principal
occupation of each director and executive officer of Cardinal
Health, Inc. as of February 9, 1996. Unless otherwise
indicated below, the business address of each such director
and executive officer is c/o Cardinal Health, Inc., 5555
Glendon Court, Dublin, Ohio 43016.
Name Principal Occupation Address
Directors
of Cardinal
Health, Inc.:
John F. Finn Chairman and Chief Executive
Officer of Gardner, Inc., an
outdoor power equipment dis-
tributor.
Robert L. Gerbig President and Chief
Executive Officer of
Gerbig, Snell/Weisheimer
& Associates, Inc., an
advertising agency.
John F. Havens Retired Chairman and Director
Emeritus of Banc One Corpora-
tion, a bank holding company.
Regina E. Herzlinger Professor, Harvard University
Graduate School of Business
Administration.
John C. Kane President and Chief Operating
Officer of Cardinal Health,
Inc.
George R. Manser Chairman of Uniglobe
Travel (Capital Cities)
Inc., a travel planning
services company.
John B. McCoy Chairman and Chief Executive
Officer of Banc One Corpora-
tion, a bank holding company.
Page 8 of 11<PAGE>
CUSIP NO. 747251106
Jerry E. Robertson Retired Executive Vice
President of the Life Sciences
Sector and Corporate Services
of Minnesota Mining & Manu-
facturing Company, a manu-
facturer of industrial
commercial, health care and
consumer products.
L. Jack Van Fossen Retired President and Chief
Executive Officer of Red Roof
Inns, Inc., a lodging company.
Robert D. Walter Chairman and Chief Executive
Officer of Cardinal Health,
Inc.
Melburn G. Whitmire Vice Chairman of Cardinal
Health, Inc.
Executive Officers
of Cardinal Health, Inc.
(that are not directors):
David Bearman Executive Vice President and
Chief Financial Officer.
George H. Bennett, Jr. Executive Vice President,
General Counsel and Secretary.
Anthony J. Campanaro Executive Vice President-
Central Group.
James E. Clare Executive Vice President-
Southern Group.
Gary E. Close Executive Vice President-
Western Group.
Phillip A. Greth Executive Vice President
and Chief Information
Officer.
James F. Millar Executive Vice President-
Distribution Operations
Gordon A. Troup Executive Vice President-
Northern Group.
Page 9 of 11<PAGE>
CUSIP NO. 747251106 ANNEX II
Persons Executing Support/Voting Agreements
Dick P. Allen and certain affiliates
Ronald R. Taylor
Timothy J. Wollaeger
Page 10 of 11<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set
forth in this statement is true, complete and correct.
CARDINAL HEALTH, INC.
By: /s/ George H. Bennett, Jr.
Name: George H. Bennett, Jr.
Title: Executive Vice President,
General Counsel and Secretary
Dated: February 12, 1996
Page 11 of 11<PAGE>
EXHIBIT INDEX
Exhibit Description
2.1 Agreement and Plan of
Merger, dated February 7,
1996, among Cardinal Health, Inc.,
Aztec Merger Corp. and Pyxis
Corporation
2.2 Stock Option Agreement, dated
February 7, 1996, between
Cardinal Health, Inc. and Pyxis
Corporation
99.1 Form of Support/Voting Agreement.
AGREEMENT AND PLAN OF MERGER
AMONG
CARDINAL HEALTH, INC.
("Cardinal"),
AZTEC MERGER CORP.
a wholly owned direct subsidiary of Cardinal
("Subcorp"),
and
PYXIS CORPORATION
("Pyxis")
February 7, 1996<PAGE>
TABLE OF CONTENTS
PAGE
AGREEMENT AND PLAN OF MERGER............................. 1
PRELIMINARY STATEMENTS................................... 1
AGREEMENT................................................ 1
ARTICLE I: THE MERGER................................... 1
1.1 The Merger................................... 1
1.2 Effective Time............................... 2
1.3 Effects of the Merger........................ 2
1.4 Certificate of Incorporation and Bylaws...... 2
1.5 Directors and Officers....................... 2
1.6 Additional Actions........................... 2
ARTICLE II: CONVERSION OF SECURITIES.................... 3
2.1 Conversion of Capital Stock.................. 3
2.2 Exchange Ratio; Fractional Shares............ 3
2.3 Exchange of Certificates..................... 4
(a) Exchange Agent........................... 4
(b) Exchange Procedures...................... 4
(c) Distributions with Respect to
Unexchanged Shares...................... 4
(d) No Further Ownership Rights in
Pyxis Common Stock...................... 5
(e) Termination of Exchange Fund............. 5
(f) No Liability............................. 5
(g) Investment of Exchange Fund.............. 5
2.4 Treatment of Stock Options;
Stock Purchase Plan........................ 6
ARTICLE III: REPRESENTATIONS AND WARRANTIES OF
CARDINAL AND SUBCORP......................... 6
3.1 Organization and Standing.................... 7
3.2 Corporate Power and Authority................ 7
3.3 Capitalization of Cardinal................... 7
3.4 Conflicts, Consents and Approval............. 8
3.5 Brokerage and Finder's Fees.................. 8
3.6 Accounting Matters........................... 8
3.7 Cardinal SEC Documents....................... 9
3.8 Registration Statement....................... 9
3.9 Compliance with Law.......................... 9
3.10 Litigation................................... 10
3.11 No Material Adverse Change................... 10
3.12 Board Recommendation......................... 10
3.13 Undisclosed Liabilities...................... 10
-i-<PAGE>
PAGE
ARTICLE IV: REPRESENTATIONS AND WARRANTIES OF
PYXIS..................................... 11
4.1 Organization and Standing.................... 11
4.2 Subsidiaries................................. 11
4.3 Corporate Power and Authority................ 11
4.4 Capitalization of Pyxis...................... 12
4.5 Conflicts; Consents and Approvals............ 12
4.6 No Material Adverse Change................... 13
4.7 Pyxis SEC Documents.......................... 13
4.8 Taxes........................................ 14
4.9 Compliance with Law.......................... 14
4.10 Intellectual Property........................ 14
4.11 Title to and Condition of Properties......... 16
4.12 Registration Statement....................... 16
4.13 Litigation................................... 17
4.14 Brokerage and Finder's Fees; Expenses........ 17
4.15 Accounting Matters........................... 17
4.16 Employee Benefit Plans....................... 17
4.17 Contracts.................................... 19
4.18 Accounts Receivable.......................... 20
4.19 Labor Relations.............................. 20
4.20 Undisclosed Liabilities...................... 21
4.21 Operation of Pyxis's Business;
Relationships.............................. 21
4.22 Permits; Compliance.......................... 21
4.23 Product Warranties and Liabilities........... 21
4.24 Environmental Matters........................ 22
4.25 Opinion of Financial Advisor................. 22
4.26 Board Recommendation......................... 22
4.27 DGCL Section 203 and State Takeover Laws..... 23
4.28 Lease Arrangements........................... 23
4.29 [Intentionally Omitted]...................... 23
4.30 Pyxis Rights Agreement....................... 23
ARTICLE V: COVENANTS OF THE PARTIES..................... 24
5.1 Mutual Covenants............................. 24
(a) General................................. 24
(b) HSR Act................................. 24
(c) Other Governmental Matters.............. 24
(d) Pooling-of-Interests.................... 24
(e) Tax-Free Treatment...................... 24
(f) Public Announcements.................... 24
(g) Access.................................. 25
(h) Directors' and Officers' Insurance...... 25
5.2 Covenants of Cardinal........................ 25
(a) Cardinal Shareholders Meeting........... 25
(b) Preparation of Joint Proxy Statement.... 25
(c) Conduct of Cardinal's Operations........ 25
(d) Indemnification......................... 26
-ii-<PAGE>
PAGE
(e) Employee Benefits....................... 26
(f) Notification of Certain Matters......... 26
5.3 Covenants of Pyxis........................... 26
(a) Pyxis Stockholders Meeting.............. 26
(b) Information for the Registration Statement
and Preparation of Joint Proxy
Statement............................ 26
(c) Conduct of Pyxis's Operations........... 27
(d) Intellectual Property Matters........... 29
(e) No Solicitation......................... 29
(f) Affiliates of Pyxis..................... 30
(g) Notification of Certain Matters......... 30
(h) Employment Agreements................... 30
ARTICLE VI: CONDITIONS.................................. 30
6.1 Mutual Conditions............................ 30
6.2 Conditions to Obligations of Pyxis........... 31
6.3 Conditions to Obligations of Cardinal and
Subcorp.................................... 32
ARTICLE VII: TERMINATION AND AMENDMENT.................. 33
7.1 Termination.................................. 33
7.2 Effect of Termination........................ 34
7.3 Amendment.................................... 35
7.4 Extension; Waiver............................ 35
ARTICLE VIII: MISCELLANEOUS............................. 35
8.1 Survival of Representations and
Warranties................................. 35
8.2 Notices...................................... 35
8.3 Interpretation............................... 36
8.4 Counterparts................................. 36
8.5 Entire Agreement............................. 36
8.6 Third Party Beneficiaries.................... 37
8.7 Governing Law................................ 37
8.8 Specific Performance......................... 37
8.9 Assignment................................... 37
8.10 Expenses..................................... 37
8.11 Pyxis Disclosure Schedule.................... 37
-iii-<PAGE>
AGREEMENT AND PLAN OF MERGER
This Agreement and Plan of Merger (this "Agreement")
is made and entered into as of the 7th day of February, 1996,
by and among Cardinal Health, Inc., an Ohio corporation
("Cardinal"), Aztec Merger Corp., a Delaware corporation and a
wholly owned subsidiary of Cardinal ("Subcorp"), and Pyxis
Corporation, a Delaware corporation ("Pyxis").
PRELIMINARY STATEMENTS
A. Cardinal desires to acquire the healthcare auto-
mation and information business and other businesses operated
by Pyxis through the merger (the "Merger") of Subcorp with and
into Pyxis, with Pyxis as the surviving corporation, pursuant
to which each share of Pyxis Common Stock (as defined in Sec-
tion 4.4) outstanding at the Effective Time (as defined in Sec-
tion 1.2) will be converted into the right to receive Cardinal
Common Shares (as defined in Section 3.3) as more fully pro-
vided herein.
B. Pyxis desires to combine its healthcare automa-
tion and information and other businesses with the wholesale
drug distribution and related businesses operated by Cardinal
and for the holders of shares of Pyxis Common Stock ("Pyxis
Stockholders") to have a continuing equity interest in the com-
bined Cardinal/Pyxis businesses.
C. The parties intend that the Merger constitute a
tax-free "reorganization" within the meaning of Section
368(a)(1)(A) of the Internal Revenue Code of 1986, as amended
(the "Code"), by reason of Section 368(a)(2)(E) thereof.
D. The parties intend that the Merger be accounted
for as a pooling-of-interests for financial reporting purposes.
E. The respective Boards of Directors of Cardinal,
Subcorp and Pyxis have determined the Merger in the manner con-
templated herein to be desirable and in the best interests of
their respective shareholders and, by resolutions duly adopted,
have approved and adopted this Agreement.
AGREEMENT
Now, therefore, in consideration of these premises
and the mutual and dependent promises hereinafter set forth,
the parties hereto agree as follows:<PAGE>
ARTICLE I
THE MERGER
1.1 The Merger. Upon the terms and subject to the
conditions hereof, and in accordance with the provisions of the
Delaware General Corporation Law (the "DGCL"), Subcorp shall be
merged with and into Pyxis as soon as practicable following the
satisfaction or waiver of the conditions set forth in Article
VI. Following the Merger, the separate corporate existence of
Subcorp shall cease and Pyxis shall continue its existence un-
der the laws of the State of Delaware. Pyxis, in its capacity
as the corporation surviving the Merger, is hereinafter some-
times referred to as the "Surviving Corporation."
1.2 Effective Time. The Merger shall be consummated
by filing with the Secretary of State of the State of Delaware
(the "Delaware Secretary of State") a certificate of merger
(the "Certificate of Merger") in such form as is required by
and executed in accordance with Section 251(c) of the DGCL.
The Merger shall become effective (the "Effective Time") when
the Certificate of Merger has been filed with the Delaware Sec-
retary of State or at such later time as shall be specified in
the Certificate of Merger. Prior to the filing referred to in
this Section 1.2, a closing (the "Closing") shall be held at
the offices of Cardinal, 5555 Glendon Court, Dublin, Ohio
43016, or such other place as the parties may agree on a date
(the "Closing Date") specified by the parties, which date shall
be as soon as practicable, but in any event within ten business
days, following the date upon which all conditions set forth in
Article VI hereof have been satisfied or waived or such other
time as the parties may mutually agree.
1.3 Effects of the Merger. The Merger shall have
the effects set forth in Section 259 of the DGCL.
1.4 Certificate of Incorporation and Bylaws. The
Certificate of Merger shall provide that at the Effective Time
(i) the Certificate of Incorporation of the Surviving Corpora-
tion as in effect immediately prior to the Effective Time shall
be amended as of the Effective Time so as to contain the provi-
sions, and only the provisions, contained immediately prior
thereto in the Certificate of Incorporation of Subcorp, except
for Article I thereof which shall continue to read "The name of
the corporation is 'Pyxis Corporation'", and (ii) the By-laws
of Pyxis in effect immediately prior to the Effective Time
shall be the By-laws of the Surviving Corporation, amended as
of the Effective Time so as to contain the provisions, and only
the provisions, contained in the Bylaws of Subcorp immediately
-2-<PAGE>
prior thereto; in each case until amended in accordance with
applicable law.
1.5 Directors and Officers. From and after the Ef-
fective Time, the officers of Pyxis shall be the officers of
the Surviving Corporation and the directors of Subcorp shall be
the directors of the Surviving Corporation, in each case until
their respective successors are duly elected and qualified. On
or prior to the Closing Date, Pyxis shall deliver to Cardinal
evidence satisfactory to Cardinal of the resignations of the
directors of Pyxis, such resignations to be effective as of the
Effective Time.
1.6 Additional Actions. If, at any time after the
Effective Time, the Surviving Corporation shall consider or be
advised that any further deeds, assignments or assurances in
law or any other acts are necessary or desirable to (a) vest,
perfect or confirm, of record or otherwise, in the Surviving
Corporation its right, title or interest in, to or under any of
the rights, properties or assets of Pyxis, or (b) otherwise
carry out the provisions of this Agreement, Pyxis and its of-
ficers and directors shall be deemed to have granted to the
Surviving Corporation an irrevocable power of attorney to ex-
ecute and deliver all such deeds, assignments or assurances in
law and to take all acts necessary, proper or desirable to
vest, perfect or confirm title to and possession of such
rights, properties or assets in the Surviving Corporation and
otherwise to carry out the provisions of this Agreement, and
the officers and directors of the Surviving Corporation are
authorized in the name of Pyxis or otherwise to take any and
all such action.
ARTICLE II
CONVERSION OF SECURITIES
2.1 Conversion of Capital Stock. At the Effective
Time, by virtue of the Merger and without any action on the
part of Cardinal, Subcorp or Pyxis:
(a) Each share of common stock, $0.01 par value, of
Subcorp issued and outstanding immediately prior to the
Effective Time shall be converted into one share of common
stock, $0.01 par value, of the Surviving Corporation.
Such newly issued shares shall thereafter constitute all
of the issued and outstanding capital stock of the Surviv-
ing Corporation.
-3-<PAGE>
(b) Each share of Pyxis Common Stock issued and out-
standing immediately prior to the Effective Time shall be
converted into and represent a number of Cardinal Common
Shares equal to the Exchange Ratio (as defined below).
(c) Each share of capital stock of Pyxis held in the
treasury of Pyxis shall be cancelled and retired and no
payment shall be made in respect thereof.
2.2 Exchange Ratio; Fractional Shares. The "Ex-
change Ratio" shall equal (i) if Cardinal has not made an Ad-
justment Election (as defined in Section 7.1(d)), .406557 or
(ii) if Cardinal has made an Adjustment Election, then the
product of (x) .406557 and (y) the quotient obtained by
dividing 55.34 by the average of the closing prices of Cardinal
Common Shares as reported on the New York Stock Exchange
("NYSE") Composite Tape ("NYSE Composite Tape") on each of the
last ten trading days ending on the sixth trading day prior to
the earlier of (I) the meeting of Pyxis Stockholders at which
the vote to approve the Merger occurs or (II) the meeting of
holders of Cardinal Common Shares ("Cardinal Shareholders") at
which the vote to approve and authorize the issuance of
Cardinal Common Shares in the Merger occurs (the "Average Share
Price"). No certificates for fractional Cardinal Common Shares
shall be issued as a result of the conversion provided for in
Section 2.1(b). To the extent that an outstanding share of
Pyxis Common Stock would otherwise have become a fractional
Cardinal Common Share, the holder thereof, upon presentation of
such fractional interest represented by an appropriate certifi-
cate for Pyxis Common Stock to the Exchange Agent pursuant to
Section 2.3, shall be entitled to receive a cash payment
therefor in an amount equal to the value (determined with
reference to the closing price of Cardinal Common Shares on the
NYSE Composite Tape on the last full trading day immediately
prior to the Effective Time) of such fractional interest. Such
payment with respect to fractional shares is merely intended to
provide a mechanical rounding off of, and is not a separately
bargained for, consideration. If more than one certificate
representing shares of Pyxis Common Stock shall be surrendered
for the account of the same holder, the number of Cardinal
Common Shares for which certificates have been surrendered
shall be computed on the basis of the aggregate number of
shares represented by the certificates so surrendered. In the
event that prior to the Effective Time Cardinal shall declare a
stock dividend or other distribution payable in Cardinal Common
Shares or securities convertible into Cardinal Common Shares,
or effect a stock split, reclassification, combination or other
change with respect to Cardinal Common Shares, the Exchange
Ratio set forth in this Section 2.2 shall be adjusted to
-4-<PAGE>
reflect such dividend, distribution, stock split,
reclassification, combination or other change.
2.3 Exchange of Certificates.
(a) Exchange Agent. Promptly following the Effec-
tive Time, Cardinal shall deposit with Boatmen's Trust Company
or such other exchange agent as may be designated by Cardinal
(the "Exchange Agent"), for the benefit of Pyxis Stockholders,
for exchange in accordance with this Section 2.3, certificates
representing Cardinal Common Shares issuable pursuant to
Section 2.1 in exchange for outstanding shares of Pyxis Common
Stock and shall from time-to-time deposit cash in an amount
reasonably expected to be paid pursuant to Section 2.2 (such
Cardinal Common Shares and cash, together with any dividends or
distributions with respect thereto, being hereinafter referred
to as the "Exchange Fund").
(b) Exchange Procedures. As soon as practicable
after the Effective Time, the Exchange Agent shall mail to each
holder of record of a certificate or certificates (the "Cer-
tificates") which immediately prior to the Effective Time rep-
resented outstanding shares of Pyxis Common Stock whose shares
were converted into the right to receive Cardinal Common Shares
pursuant to Section 2.1(b) (i) a letter of transmittal (which
shall specify that delivery shall be effected, and risk of loss
and title to the Certificates shall pass, only upon delivery of
the Certificates to the Exchange Agent and shall be in such
form and have such other provisions as Cardinal may reasonably
specify) and (ii) instructions for effecting the surrender of
the Certificates in exchange for certificates representing
Cardinal Common Shares. Upon surrender of a Certificate for
cancellation to the Exchange Agent, together with a duly ex-
ecuted letter of transmittal, the holder of such Certificate
shall be entitled to receive in exchange therefor (x) a cer-
tificate representing that number of Cardinal Common Shares
which such holder has the right to receive pursuant to Section
2.1 and (y) a check representing the amount of cash in lieu of
fractional shares, if any, and unpaid dividends and distribu-
tions, if any, which such holder has the right to receive pur-
suant to the provisions of this Article II, after giving effect
to any required withholding tax, and the shares represented by
the Certificate so surrendered shall forthwith be cancelled.
No interest will be paid or accrued on the cash in lieu of
fractional shares, if any, and unpaid dividends and distribu-
tions, if any, payable to holders of shares of Pyxis Common
Stock. In the event of a transfer of ownership of shares of
Pyxis Common Stock which is not registered on the transfer
records of Pyxis, a certificate representing the proper number
of Cardinal Common Shares, together with a check for the cash
-5-<PAGE>
to be paid in lieu of fractional shares, if any, and unpaid
dividends and distributions, if any, may be issued to such
transferee if the Certificate representing such shares of Pyxis
Common Stock held by such transferee is presented to the
Exchange Agent, accompanied by all documents required to evi-
dence and effect such transfer and to evidence that any appli-
cable stock transfer taxes have been paid. Until surrendered
as contemplated by this Section 2.3, each Certificate shall be
deemed at any time after the Effective Time to represent only
the right to receive upon surrender a certificate representing
Cardinal Common Shares and cash in lieu of fractional shares,
if any, and unpaid dividends and distributions, if any, as pro-
vided in this Article II.
(c) Distributions with Respect to Unexchanged
Shares. Notwithstanding any other provisions of this Agree-
ment, no dividends or other distributions declared or made af-
ter the Effective Time with respect to Cardinal Common Shares
having a record date after the Effective Time shall be paid to
the holder of any unsurrendered Certificate, and no cash pay-
ment in lieu of fractional shares shall be paid to any such
holder, until the holder shall surrender such Certificate as
provided in this Section 2.3. Subject to the effect of Appli-
cable Laws (as defined in Section 3.9), following surrender of
any such Certificate, there shall be paid to the holder of the
certificates representing whole Cardinal Common Shares issued
in exchange therefor, without interest, (i) at the time of such
surrender, the amount of dividends or other distributions with
a record date after the Effective Time theretofore payable with
respect to such whole Cardinal Common Shares and not paid, less
the amount of any withholding taxes which may be required
thereon, and (ii) at the appropriate payment date subsequent to
surrender, the amount of dividends or other distributions with
a record date after the Effective Time but prior to surrender
and a payment date subsequent to surrender payable with respect
to such whole Cardinal Common Shares, less the amount of any
withholding taxes which may be required thereon.
(d) No Further Ownership Rights in Pyxis Common
Stock. All Cardinal Common Shares issued upon surrender of
Certificates in accordance with the terms hereof (including any
cash paid pursuant to this Article II) shall be deemed to have
been issued in full satisfaction of all rights pertaining to
such shares of Pyxis Common Stock represented thereby, and from
and after the Effective Time there shall be no further regis-
tration of transfers on the stock transfer books of Pyxis of
shares of Pyxis Common Stock. If, after the Effective Time,
Certificates are presented to the Surviving Corporation for any
reason, they shall be cancelled and exchanged as provided in
this Section 2.3. Certificates surrendered for exchange by any
-6-<PAGE>
person constituting an "affiliate" of Pyxis for purposes of
Rule 145(c) under the Securities Act of 1933, as amended (the
"Securities Act"), shall not be exchanged until Cardinal has
received written undertakings from such person in the form at-
tached hereto as Exhibit A.
(e) Termination of Exchange Fund. Any portion of
the Exchange Fund which remains undistributed to Pyxis Stock-
holders for six months after the Effective Time shall be deliv-
ered to Cardinal, upon demand thereby, and holders of shares of
Pyxis Common Stock who have not theretofore complied with this
Section 2.3 shall thereafter look only to Cardinal for payment
of any claim to Cardinal Common Shares, cash in lieu of frac-
tional shares thereof, or dividends or distributions, if any,
in respect thereof.
(f) No Liability. None of Cardinal, the Surviving
Corporation or the Exchange Agent shall be liable to any person
in respect of any shares of Pyxis Common Stock (or dividends or
distributions with respect thereto) or cash from the Exchange
Fund delivered to a public official pursuant to any applicable
abandoned property, escheat or similar law. If any Certifi-
cates shall not have been surrendered prior to seven years af-
ter the Effective Time of the Merger (or immediately prior to
such earlier date on which any cash, any cash in lieu of frac-
tional shares or any dividends or distributions with respect to
whole shares of Pyxis Common Stock in respect of such Certifi-
cate would otherwise escheat to or become the property of any
Governmental Authority (as defined in Section 3.4)), any such
cash, dividends or distributions in respect of such Certificate
shall, to the extent permitted by Applicable Law (as defined in
Section 3.9), become the property of Cardinal, free and clear
of all claims or interest of any person previously entitled
thereto.
(g) Investment of Exchange Fund. The Exchange Agent
shall invest any cash included in the Exchange Fund, as di-
rected by Cardinal, on a daily basis. Any interest and other
income resulting from such investments shall be paid to
Cardinal upon termination of the Exchange Fund pursuant to
Section 2.3(e).
2.4 Treatment of Stock Options; Stock Purchase Plan.
(a) Prior to the Effective Time, Cardinal and Pyxis
shall take all such actions as may be necessary to cause each
unexpired and unexercised option under stock option plans of
Pyxis in effect on the date hereof which has been granted to
current or former directors, officers, employees, consultants
or independent contractors of Pyxis by Pyxis (each, an "Pyxis
-7-<PAGE>
Option") to be automatically converted at the Effective Time
into an option (a "Cardinal Exchange Option") to purchase that
number of Cardinal Common Shares equal to the number of shares
of Pyxis Common Stock issuable immediately prior to the Effec-
tive Time upon exercise of the Pyxis Option (without regard to
actual restrictions on exercisability) multiplied by the Ex-
change Ratio, with an exercise price equal to the exercise
price which existed under the corresponding Pyxis Option di-
vided by the Exchange Ratio, and with other terms and condi-
tions that are the same as the terms and conditions of such
Pyxis Option immediately before the Effective Time; provided
that with respect to any Pyxis Option that is an "incentive
stock option" within the meaning of Section 422 of the Code,
the foregoing conversion shall be carried out in a manner sat-
isfying the requirements of Section 424(a) of the Code. In
connection with the issuance of Cardinal Exchange Options,
Cardinal shall (i) reserve for issuance the number of Cardinal
Common Shares that will become subject to Cardinal Exchange Op-
tions pursuant to this Section 2.4 and (ii) from and after the
Effective Time, upon exercise of Cardinal Exchange Options,
make available for issuance all Cardinal Common Shares covered
thereby, subject to the terms and conditions applicable
thereto.
(b) Pyxis agrees to issue treasury shares of Pyxis,
to the extent available, upon the exercise of Pyxis Options
prior to the Effective Time.
(c) Cardinal agrees to file with the Securities and
Exchange Commission (the "Commission") as soon as reasonably
practicable after the Closing Date a registration statement on
Form S-8 or other appropriate form under the Securities Act to
register Cardinal Common Shares issuable upon exercise of the
Cardinal Exchange Options and use its reasonable efforts to
cause such registration statement to remain effective until the
exercise or expiration of such options.
(d) Pyxis shall terminate the Pyxis Employee Stock
Purchase Plan (the "Pyxis Purchase Plan") immediately prior to
the Effective Time. Unless Cardinal and Pyxis shall otherwise
agree in writing prior to the Effective Time, all amounts that
have been withheld but not yet applied to purchase Pyxis Common
Stock pursuant to the Pyxis Purchase Plan as of the termination
date shall be refunded, without interest, pursuant to the terms
of the Pyxis Purchase Plan.
-8-<PAGE>
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF CARDINAL AND SUBCORP
In order to induce Pyxis to enter into this Agree-
ment, Cardinal and Subcorp hereby represent and warrant to
Pyxis that the statements contained in this Article III are
true, correct and complete.
3.1 Organization and Standing. Each of Cardinal and
Subcorp is a corporation duly organized, validly existing and
in good standing under the laws of its state of incorporation
with full power and authority (corporate and other) to own,
lease, use and operate its properties and to conduct its busi-
ness as and where now owned, leased, used, operated and con-
ducted. Each of Cardinal and Subcorp is duly qualified to do
business and in good standing in each jurisdiction in which the
nature of the business conducted by it or the property it owns,
leases or operates, makes such qualification necessary, except
where the failure to be so qualified or in good standing in
such jurisdiction would not have a material adverse effect on
Cardinal. Cardinal is not in default in the performance,
observance or fulfillment of any provision of its Articles of
Incorporation, as amended and restated (the "Cardinal
Articles"), or Code of Regulations, as amended and restated,
and Subcorp is not in default in the performance, observance or
fulfillment of any provisions of its Certificate of Incorpora-
tion or Bylaws.
3.2 Corporate Power and Authority. Each of Cardinal
and Subcorp has all requisite corporate power and authority to
enter into this Agreement and, subject to authorization of the
issuance of Cardinal Common Shares issuable in the Merger and
the transactions contemplated hereby by the holders of Cardinal
Common Shares ("Cardinal Shareholders"), to consummate the
transactions contemplated by this Agreement. The execution and
delivery of this Agreement and the consummation of the transac-
tions contemplated hereby have been duly authorized by all nec-
essary corporate action on the part of each of Cardinal and
Subcorp, subject to authorization of the issuance of Cardinal
Common Shares issuable in the Merger and the transactions con-
templated hereby by Cardinal Shareholders. This Agreement has
been duly executed and delivered by each of Cardinal and Sub-
corp, and constitutes the legal, valid and binding obligation
of each of Subcorp and Cardinal enforceable against each of
them in accordance with its terms.
3.3 Capitalization of Cardinal. As of January 31,
1996, Cardinal's authorized capital stock consisted solely of
(a) 100,000,000 common shares, without par value ("Cardinal
-9-<PAGE>
Common Shares"), of which (i) 48,654,584 shares were issued and
outstanding, (ii) 203,492 shares were issued and held in
treasury (which does not include the shares reserved for issu-
ance as set forth in clause (a)(iii) below) and (iii)
3,729,200.5 shares were reserved for issuance upon the exercise
or conversion of options, warrants or convertible securities
granted or issuable by Cardinal, (b) 5,000,000 Class B common
shares, without par value ("Cardinal Class B Common Shares"),
none of which was issued and outstanding or reserved for issu-
ance, and (c) 500,000 Non-Voting Preferred Shares, without par
value, none of which was issued and outstanding or reserved for
issuance. Each outstanding share of Cardinal capital stock is,
and all Cardinal Common Shares to be issued in connection with
the Merger will be, duly authorized and validly issued, fully
paid and nonassessable, and each outstanding share of Cardinal
capital stock has not been, and all Cardinal Common Shares to
be issued in connection with the Merger will not be, issued in
violation of any preemptive or similar rights. As of the date
hereof, other than as set forth in the first sentence hereof or
in Section 3.3 to the disclosure schedule (the "Cardinal Dis-
closure Schedule") delivered by Cardinal to Pyxis and dated the
date hereof, there are no outstanding subscriptions, options,
warrants, puts, calls, agreements, understandings, claims or
other commitments or rights of any type relating to the issu-
ance, sale or transfer by Cardinal of any equity securities of
Cardinal, nor are there outstanding any securities which are
convertible into or exchangeable for any shares of capital
stock of Cardinal. Except as set forth in Section 3.3 to the
Cardinal Disclosure Schedule, Cardinal has not agreed to
register any securities under the Securities Act or under any
state securities law or granted registration rights to any
person or entity.
3.4 Conflicts, Consents and Approval. Neither the
execution and delivery of this Agreement by Cardinal or Subcorp
nor the consummation of the transactions contemplated hereby
will:
(a) conflict with, or result in a breach of any pro-
vision of the Cardinal Articles or Code of Regulations, as
amended and restated, of Cardinal or the Certificate of
Incorporation or Bylaws of Subcorp;
(b) violate, or conflict with, or result in a breach
of any provision of, or constitute a default (or an event
which, with the giving of notice, the passage of time or
otherwise, would constitute a default) under, or entitle
any party (with the giving of notice, the passage of time
or otherwise) to terminate, accelerate, modify or call a
-10-<PAGE>
default under, or result in the creation of any lien, se-
curity interest, charge or encumbrance upon any of the
properties or assets of Cardinal or any of its subsidiar-
ies under, any of the terms, conditions or provisions of
any note, bond, mortgage, indenture, deed of trust, li-
cense, contract, undertaking, agreement, lease or other
instrument or obligation to which Cardinal or any of its
subsidiaries is a party;
(c) violate any order, writ, injunction, decree,
statute, rule or regulation, applicable to Cardinal or any
of its subsidiaries or their respective properties or as-
sets; or
(d) require any action or consent or approval of, or
review by, or registration or filing by Cardinal or any of
its affiliates with any third party or any court, arbitral
tribunal, administrative agency or commission or other
governmental or regulatory body, agency, instrumentality
or authority (a "Governmental Authority"), other than (i)
authorization of the issuance of Cardinal Common Shares
issuable in the Merger and the transactions contemplated
hereby by Cardinal Shareholders, (ii) authorization for
inclusion of the Cardinal Common Shares to be issued in
the Merger and the transactions contemplated hereby on the
NYSE, subject to official notice of issuance, (iii) ac-
tions required by the Hart-Scott-Rodino Antitrust Improve-
ments Act of 1976, as amended, and the rules and regula-
tions promulgated thereunder (the "HSR Act"), and (iv)
registrations or other actions required under federal and
state securities laws as are contemplated by this Agree-
ment;
except in the case of (b), (c) and (d) for any of the foregoing
that would not, individually or in the aggregate, have a mate-
rial adverse effect on Cardinal.
3.5 Brokerage and Finder's Fees. Except for
Cardinal's obligation to Smith Barney Inc. ("Smith Barney"),
neither Cardinal nor any shareholder, director, officer or em-
ployee thereof, has incurred or will incur on behalf of
Cardinal, any brokerage, finder's or similar fee in connection
with the transactions contemplated by this Agreement.
3.6 Accounting Matters. Neither Cardinal nor any of
its affiliates has taken or agreed to take any action that
(without giving effect to any actions taken or agreed to be
taken by Pyxis or any of its affiliates) would prevent Cardinal
from accounting for the business combination to be effected by
-11-<PAGE>
the Merger as a pooling-of-interests for financial reporting
purposes.
3.7 Cardinal SEC Documents. Cardinal has timely
filed with the Commission all forms, reports, schedules, state-
ments and other documents required to be filed by it since
December 31, 1992 under the Securities Exchange Act of 1934, as
amended (together with the rules and regulations thereunder,
the "Exchange Act") or the Securities Act (such documents, as
supplemented and amended since the time of filing, collec-
tively, the "Cardinal SEC Documents"). The Cardinal SEC Docu-
ments, including, without limitation, any financial statements
or schedules included therein, at the time filed (and, in the
case of registration statements and proxy statements, on the
dates of effectiveness and the dates of mailing, respectively)
(a) did not contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein or
necessary in order to make the statements therein, in light of
the circumstances under which they were made, not misleading,
and (b) complied in all material respects with the applicable
requirements of the Exchange Act and the Securities Act, as the
case may be. The financial statements of Cardinal included in
the Cardinal SEC Documents at the time filed (and, in the case
of registration statements and proxy statements, on the date of
effectiveness and the date of mailing, respectively) complied
as to form in all material respects with applicable accounting
requirements and with the published rules and regulations of
the Commission with respect thereto, were prepared in ac-
cordance with generally accepted accounting principles applied
on a consistent basis during the periods involved (except as
may be indicated in the notes thereto or, in the case of unau-
dited statements, as permitted by Form 10-Q of the Commission),
and fairly present (subject in the case of unaudited statements
to normal, recurring audit adjustments) the consolidated finan-
cial position of Cardinal and its consolidated subsidiaries as
at the dates thereof and the consolidated results of their op-
erations and cash flows for the periods then ended.
3.8 Registration Statement. None of the information
provided by Cardinal for inclusion in the registration state-
ment on Form S-4 to be filed with the Commission by Cardinal
under the Securities Act, including the prospectus (as amended,
supplemented or modified, the "Prospectus") relating to
Cardinal Common Shares to be issued in the Merger and the joint
proxy statement and form of proxies relating to the vote of
Pyxis Stockholders with respect to the Merger and the vote of
Cardinal Shareholders with respect to the Merger (collectively
and as amended, supplemented or modified, the "Joint Proxy
Statement") contained therein (such registration statement as
amended, supplemented or modified, the "Registration
-12-<PAGE>
Statement"), at the time the Registration Statement becomes
effective or, in the case of the Joint Proxy Statement, at the
date of mailing, will contain any untrue statement of a
material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are
made, not misleading. Each of the Registration Statement and
Joint Proxy Statement, except for such portions thereof that
relate only to Pyxis, will comply as to form in all material
respects with the provisions of the Securities Act and Exchange
Act.
3.9 Compliance with Law. Cardinal is in compliance
with, and at all times since December 31, 1992 has been in com-
pliance with, all applicable laws, statutes, orders, rules,
regulations, policies or guidelines promulgated, or judgments,
decisions or orders entered by any Governmental Authority (col-
lectively, "Applicable Laws") relating to Cardinal or its busi-
ness or properties, except where the failure to be in compli-
ance therewith could not reasonably be expected to have a mate-
rial adverse effect on Cardinal.
3.10 Litigation. Except as set forth in Section
3.10 to the Cardinal Disclosure Schedule delivered by Cardinal
to Pyxis and dated the date hereof or in the Cardinal SEC Docu-
ments, there is no suit, claim, action, proceeding or investi-
gation (an "Action") pending or, to the knowledge of Cardinal,
threatened against Cardinal which, individually or in the ag-
gregate, could reasonably be expected to have a material ad-
verse effect on Cardinal or a material adverse effect on the
ability of Cardinal to consummate the transactions contemplated
hereby. Cardinal is not subject to any outstanding order,
writ, injunction or decree which, individually or in the
aggregate, insofar as can be reasonably foreseen, could have a
material adverse effect on Cardinal or a material adverse
effect on the ability of Cardinal to consummate the
transactions contemplated hereby. Except as set forth in
Section 3.10 to the Cardinal Disclosure Schedule, since Decem-
ber 31, 1992, Cardinal has not been subject to any outstanding
order, writ, injunction or decree relating to Cardinal's method
of doing business or its relationship with past, existing or
future users or purchasers of any goods or services of
Cardinal.
3.11 No Material Adverse Change. Except as set
forth in Section 3.11 to the Cardinal Disclosure Schedule,
since June 30, 1995, Cardinal has conducted its business in the
ordinary course, consistent with past practice, and there has
been no (i) material adverse change in the assets, liabilities,
results of operations, business or financial condition of
-13-<PAGE>
Cardinal and its subsidiaries taken as a whole or (ii) material
adverse effect on the ability of Cardinal to consummate the
transactions contemplated hereby.
3.12 Board Recommendation. The Board of Directors
of Cardinal, at a meeting duly called and held, has by
unanimous vote of those directors present (who constituted 100%
of the directors then in office) (i) determined that this
Agreement and the transactions contemplated hereby, including
the Merger, taken together, are fair to and in the best
interests of Cardinal and the Cardinal Shareholders, and (ii)
resolved to recommend that the Cardinal Shareholders approve
and authorize the issuance of Cardinal Common Shares in the
Merger and the transactions contemplated hereby.
3.13 Undisclosed Liabilities. Except (i) as and to
the extent disclosed or reserved against on the supplemental
consolidated balance sheet of Cardinal as of September 30, 1995
included in the Cardinal SEC Documents, (ii) as incurred after
the date thereof in the ordinary course of business consistent
with prior practice and not prohibited by this Agreement or
(iii) as set forth in Section 3.13 to the Cardinal Disclosure
Schedule, Cardinal does not have any liabilities or obligations
of any nature, whether known or unknown, absolute, accrued,
contingent or otherwise and whether due or to become due, that,
individually or in the aggregate, have or could reasonably be
expected to have a material adverse effect on Cardinal.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF PYXIS
In order to induce Subcorp and Cardinal to enter into
this Agreement, Pyxis hereby represents and warrants to
Cardinal and Subcorp that the statements contained in this
Article IV are true, correct and complete.
4.1 Organization and Standing. Pyxis is a corpo-
ration duly organized, validly existing and in good standing
under the laws of the State of Delaware with full power and
authority (corporate and other) to own, lease, use and operate
its properties and to conduct its business as and where now
owned, leased, used, operated and conducted. Pyxis is duly
qualified to do business and in good standing in each jurisdic-
tion listed in Section 4.1 to the disclosure schedule (the
"Pyxis Disclosure Schedule") delivered by Pyxis to Cardinal and
dated the date hereof, is not qualified to do business in any
other jurisdiction and neither the nature of the business
conducted by it nor the property it owns, leases or operates
-14-<PAGE>
requires it to qualify to do business as a foreign corporation
in any other jurisdiction, except where the failure to be so
qualified or in good standing in such jurisdiction would not
have a material adverse effect on Pyxis. Pyxis is not in
default in the performance, observance or fulfillment of any
provision of its Certificate of Incorporation, as amended and
restated, or Bylaws.
4.2 Subsidiaries. Pyxis does not own, directly or
indirectly, any equity or other ownership interest in any cor-
poration, partnership, joint venture or other entity or en-
terprise, except as set forth in Section 4.2 to the Pyxis
Disclosure Schedule. Except as set forth in Section 4.2 to the
Pyxis Disclosure Schedule, Pyxis is not subject to any ob-
ligation or requirement to provide funds to or make any invest-
ment (in the form of a loan, capital contribution or otherwise)
in any such entity. Pyxis owns directly or indirectly each of
the outstanding shares of capital stock (or other ownership
interests having by their terms ordinary voting power to elect
a majority of directors or others performing similar functions
with respect to such subsidiary) of each of Pyxis's
subsidiaries. Each of the outstanding shares of capital stock
of each of Pyxis's subsidiaries is duly authorized, validly
issued, fully paid and nonassessable, and is owned, directly or
indirectly, by Pyxis free and clear of all liens, pledges,
security interests, claims or other encumbrances. The
following information for each subsidiary of Pyxis is set forth
in Section 4.2 to the Pyxis Disclosure Schedule, as applicable:
(i) its name and jurisdiction of incorporation or organization;
(ii) its authorized capital stock or share capital; and (iii)
the number of issued and outstanding shares of capital stock or
share capital and the record owner(s) thereof. Other than as
set forth in Section 4.2 to the Pyxis Disclosure Schedule,
there are no outstanding subscriptions, options, warrants,
puts, calls, agreements, understandings, claims or other com-
mitments or rights of any type relating to the issuance, sale
or transfer of any securities of any subsidiary of Pyxis, nor
are there outstanding any securities which are convertible into
or exchangeable for any shares of capital stock of any subsid-
iary of Pyxis; and no subsidiary of Pyxis has any obligation of
any kind to issue any additional securities or to pay for secu-
rities of any subsidiary of Pyxis or any predecessor thereof.
4.3 Corporate Power and Authority. Pyxis has all
requisite corporate power and authority to enter into this
Agreement and, subject to authorization of the Merger and the
transactions contemplated hereby by Pyxis Stockholders, to con-
summate the transactions contemplated by this Agreement. The
execution and delivery of this Agreement and the consummation
-15-<PAGE>
of the transactions contemplated hereby have been duly autho-
rized by all necessary corporate action on the part of Pyxis,
subject to authorization of the Merger and the transactions
contemplated hereby by Pyxis Stockholders. This Agreement has
been duly executed and delivered by Pyxis and constitutes the
legal, valid and binding obligation of Pyxis enforceable
against it in accordance with its terms.
4.4 Capitalization of Pyxis. As of February 5,
1996, Pyxis's authorized capital stock consisted solely of (a)
100,000,000 shares of common stock, $0.01 par value per share
("Pyxis Common Stock"), of which (i) 36,562,117 shares were is-
sued and outstanding, (ii) no shares were issued and held in
treasury (which does not include the shares reserved for issu-
ance set forth in clauses (iii) and (iv) below), (iii)
4,279,985 shares were reserved for issuance upon the exercise
or conversion of outstanding options, warrants or convertible
securities granted or issued by Pyxis with an average weighted
exercise price of $16.32 and (iv) 300,000 shares were reserved
for issuance under the Pyxis Purchase Plan, and (b) 10,000,000
shares of preferred stock, $0.01 par value per share ("Pyxis
Preferred Stock"), none of which was issued and outstanding or
reserved for issuance and 50,000 shares of which are designated
as "Series A Participating Preferred Stock." Each outstanding
share of Pyxis capital stock is duly authorized and validly
issued, fully paid and nonassessable, and has not been issued
in violation of any preemptive or similar rights. Other than
as set forth in the first sentence hereof, in Section 4.4 to
the Pyxis Disclosure Schedule or as contemplated by the Stock
Option Agreement (as defined in Section 4.27), there are no
outstanding subscriptions, options, warrants, puts, calls,
agreements, understandings, claims or other commitments or
rights of any type relating to the issuance, sale or transfer
of any securities of Pyxis, nor are there outstanding any secu-
rities which are convertible into or exchangeable for any
shares of capital stock of Pyxis; and Pyxis has no obligation
of any kind to issue any additional securities or to pay for
securities of Pyxis or any predecessor. The issuance and sale
of all of the shares of capital stock described in this Section
4.4 have been in compliance with federal and state securities
laws. The Pyxis Disclosure Schedule accurately sets forth the
names of, and the number of shares of each class (including,
the number of shares issuable upon exercise of Pyxis Options,
and the exercise price with respect thereto) and the number of
options and warrants held by, all holders of options or war-
rants to purchase Pyxis capital stock. Except as set forth in
Section 4.4 to the Pyxis Disclosure Schedule, Pyxis has not
agreed to register any securities under the Securities Act or
under any state securities law or granted registration rights
to any person or entity.
-16-<PAGE>
4.5 Conflicts; Consents and Approvals. Neither the
execution and delivery of this Agreement by Pyxis, nor the con-
summation of the transactions contemplated hereby will:
(a) conflict with, or result in a breach of any pro-
vision of the Certificate of Incorporation, as amended and
restated, or Bylaws of Pyxis;
(b) violate, or conflict with, or result in a breach
of any provision of, or constitute a default (or an event
which, with the giving of notice, the passage of time or
otherwise, would constitute a default) under, or entitle
any party (with the giving of notice, the passage of time
or otherwise) to terminate, accelerate, modify or call a
default under, or result in the creation of any lien, se-
curity interest, charge or encumbrance upon any of the
properties or assets of Pyxis or any of its subsidiaries
under, any of the terms, conditions or provisions of any
note, bond, mortgage, indenture, deed of trust, license,
contract, undertaking, agreement, lease or other instru-
ment or obligation to which Pyxis or any of its subsidiar-
ies is a party;
(c) violate any order, writ, injunction, decree,
statute, rule or regulation applicable to Pyxis or any of
its subsidiaries or any of their respective properties or
assets; or
(d) require any action or consent or approval of, or
review by, or registration or filing by Pyxis or any of
its affiliates with any third party or any Governmental
Authority, other than (i) authorization of the Merger and
the transactions contemplated hereby by Pyxis Sharehold-
ers, (ii) actions required by the HSR Act, (iii) registra-
tions or other actions required under federal and state
securities laws as are contemplated by this Agreement and
(iv) consents or approvals of any Governmental Authority
set forth in Section 4.5 to the Pyxis Disclosure Schedule.
except in the case of (b), (c) and (d) for any of the foregoing
that would not, individually or in the aggregate, have a mate-
rial adverse effect on Pyxis.
4.6 No Material Adverse Change. Except as set forth
in Section 4.6 to the Pyxis Disclosure Schedule, since June 30,
1995, Pyxis has conducted its business in the ordinary course,
consistent with past practice, and there has been no (i) mate-
rial adverse change in the assets, liabilities, results of op-
erations, business or financial condition of Pyxis and its sub-
sidiaries taken as a whole or (ii) material adverse effect on
-17-<PAGE>
the ability of Pyxis to consummate the transactions contem-
plated hereby.
4.7 Pyxis SEC Documents. Pyxis has timely filed
with the Commission all forms, reports, schedules, statements
and other documents required to be filed by it since December
31, 1992 under the Exchange Act or the Securities Act (such
documents, as supplemented and amended since the time of fil-
ing, collectively, the "Pyxis SEC Documents"). The Pyxis SEC
Documents, including, without limitation, any financial state-
ments or schedules included therein, at the time filed (and, in
the case of registration statements and proxy statements, on
the dates of effectiveness and the dates of mailing, respec-
tively) (a) did not contain any untrue statement of a material
fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein,
in light of the circumstances under which they were made, not
misleading, and (b) complied in all material respects with the
applicable requirements of the Exchange Act and the Securities
Act, as the case may be. The financial statements of Pyxis in-
cluded in the Pyxis SEC Documents at the time filed (and, in
the case of registration statements and proxy statements, on
the date of effectiveness and the date of mailing, respec-
tively) complied as to form in all material respects with ap-
plicable accounting requirements and with the published rules
and regulations of the Commission with respect thereto, were
prepared in accordance with generally accepted accounting prin-
ciples applied on a consistent basis during the periods in-
volved (except as may be indicated in the notes thereto or, in
the case of unaudited statements, as permitted by Form 10-Q of
the Commission), and fairly present (subject in the case of
unaudited statements to normal, recurring audit adjustments)
the consolidated financial position of Pyxis as at the dates
thereof and the consolidated results of its operations and cash
flows for the periods then ended.
4.8 Taxes. Pyxis has duly filed all federal, and
material state, local and foreign income, franchise, excise,
real and personal property and other tax returns and reports
(including, but not limited to, those filed on a consolidated,
combined or unitary basis) required to have been filed by Pyxis
prior to the date hereof. All of the foregoing returns and
reports are true and correct in all material respects, and
Pyxis has paid or, prior to the Effective Time, will pay all
taxes, interest and penalties required to be paid in respect of
the periods covered by such returns or reports to any federal,
state, foreign, local or other taxing authority. Pyxis has
paid or made adequate provision in the financial statements of
Pyxis included in the Pyxis SEC Documents for all taxes payable
in respect of all periods ending on or prior to September 30,
-18-<PAGE>
1995. Neither Pyxis nor any of its subsidiaries will have any
material liability for any taxes in excess of the amounts so
paid or reserves so established and neither Pyxis nor any of
its subsidiaries is delinquent in the payment of any material
tax, assessment or governmental charge and none of them has
requested any extension of time within which to file any re-
turns in respect of any fiscal year which have not since been
filed. No deficiencies for any tax, assessment or governmental
charge have been proposed in writing, asserted or assessed
(tentatively or definitely), in each case, by any taxing au-
thority, against Pyxis or any of its subsidiaries for which
there are not adequate reserves. Except as set forth in Sec-
tion 4.8 to the Pyxis Disclosure Schedule, neither Pyxis nor
any of its subsidiaries is the subject of any Tax audit. As of
the date of this Agreement, there are no pending requests for
waivers of the time to assess any such tax, other than those
made in the ordinary course and for which payment has been made
or there are adequate reserves. The federal income tax returns
for the years ended December 31, 1992, 1993 and 1994 of Pyxis
and its subsidiaries (excluding Allied Pharmacy Management,
Inc. and the subsidiaries thereof) are being audited by the In-
ternal Revenue Service and all federal income tax returns
through the fiscal year ending December 31, 1991 have been au-
dited by the Internal Revenue Service. For the purposes of
this Agreement, the term "tax" shall include all federal,
state, local and foreign taxes including interest and penalties
thereon. Pyxis has not filed an election under Section 341(f)
of the Code to be treated as a consenting corporation.
4.9 Compliance with Law. Except as set forth in
Section 4.9 to the Pyxis Disclosure Schedule, Pyxis is in
compliance with, and at all times since December 31, 1992 has
been in compliance with, all Applicable Laws relating to Pyxis
or its business or properties, including, without limitation,
laws regarding the provision of insurance, third party
administration and primary health care services, the
Prescription Drug Marketing Act, the Federal Controlled
Substances Act of 1970, the Food, Drug and Cosmetic Act, any
federal or state Pharmacy Practice Acts, Controlled Substance
Acts, Dangerous Drugs Acts and Food, Drug and Cosmetic Acts,
the Occupational Safety and Health Act and the regulations
promulgated thereunder ("OSHA") and all rules of professional
conduct applicable to Pyxis or by which any of its properties
are bound or subject, except where the failure to be in
compliance therewith could not reasonably be expected to have a
material adverse effect on Pyxis. Pyxis has heretofore
provided Cardinal with copies of all citations heretofore
issued to Pyxis under OSHA and made available copies of all
material correspondence from and to the Occupational Safety and
-19-<PAGE>
Health Administration, any other Governmental Authority and any
inspectors during the past three years.
4.10 Intellectual Property.
(a) Set forth in Section 4.10 to the Pyxis Disclo-
sure Schedule is a true and complete list of (i) all of Pyxis's
foreign and domestic material patents, patent applications,
invention disclosures, trademarks, service marks, tradenames
(and any registrations or applications for registration for any
of the foregoing) and all material design right and copyright
applications and registrations and (ii) all agreements to which
Pyxis is a party which concern any of the Intellectual Property
("Intellectual Property" shall mean all intellectual property
or other proprietary rights of every kind, including, without
limitation, all domestic or foreign patents, patent applica-
tions, inventions (whether or not patentable), processes, prod-
ucts, technologies, discoveries, copyrightable and copyrighted
works, apparatus, trade secrets, trademarks and trademark ap-
plications and registrations, service marks and service mark
applications and registrations, trade names, trade dress, copy-
right registrations, design rights, customer lists, marketing
and customer information, mask works rights, know-how, li-
censes, technical information (whether confidential or other-
wise), software, and all documentation thereof). Other than
the Intellectual Property set forth in Section 4.10 of the
Pyxis Disclosure Schedule, no name, patent, invention, trade
secret, proprietary right, computer software, trademark, trade
name, service mark, logo, copyright, franchise, license, subli-
cense, or other such right is necessary for the operation of
the business of Pyxis in substantially the same manner as such
business is presently or proposed to be conducted. Except as
set forth in Section 4.10 to the Pyxis Disclosure Schedule (i)
Pyxis owns, free and clear of any liens, claims or encum-
brances, the Intellectual Property and has the exclusive right
to bring actions for the infringement thereof; (ii) all of the
patents, trademark registrations, service mark registrations,
and design right registrations, and copyright registrations
included in the Intellectual Property are valid; (iii) the In-
tellectual Property does not infringe and has not infringed any
now existing or subsequently issued domestic or foreign patent,
trademark, service mark, tradename, copyright, design right or
other intellectual property or proprietary right; (iv) no per-
son or entity has asserted that, with respect to the Intel-
lectual Property, Pyxis or a licensee of Pyxis is infringing or
has infringed any domestic or foreign patent, trademark, ser-
vice mark, tradename, or copyright or design right, or has mis-
appropriated or improperly used or disclosed any trade secret,
confidential information or know-how; (v) Pyxis has no basis
for any belief that any of the Intellectual Property, or its
-20-<PAGE>
use or operation, infringe, or have infringed, any foreign or
domestic patent, trademark, service mark, tradename or copy-
right of any entity or have involved the misappropriation or
improper use or disclosure of any trade secrets, confidential
information or know-how of any entity; (vi) all working re-
quirements and all fees, annuities, and other payments which
are due from Pyxis on or before the effective date of this
Agreement for any of the Intellectual Property, including,
without limitation, all foreign or domestic patents, patent
applications, trademarks registrations, service mark registra-
tions, copyright registrations and any applications for any of
the preceding, have been met or paid; (vii) the claims made in
the foreign or domestic patents and patent applications that
are a part of the Intellectual Property are not dominated by
claims of patents owned by other persons or entities; (viii)
the making, using, selling, manufacturing, marketing, licens-
ing, reproduction, distribution, or publishing of any process,
machine, manufacture, composition of matter, or material pur-
suant to any part of the Intellectual Property, does not and
will not infringe any domestic or foreign patent, trademark,
service mark, tradename, copyright or other intellectual prop-
erty right; (ix) no unexpired foreign or domestic patents or
patent applications exist that are adverse to the material in-
terests of Pyxis; (x) the Intellectual Property is not the sub-
ject of any pending Action; (xi) no part of the Intellectual
Property was obtained through inequitable conduct or fraud in
the United States Patent and Trademark Office or any foreign
governmental entity; (xii) Pyxis is not aware of any (a) prior
act that would adversely affect, void or invalidate any of the
Intellectual Property or (b) conduct or use by Pyxis or any
third party that would adversely affect, void or invalidate any
of the Intellectual Property; (xiii) the execution, delivery
and performance of this Agreement by Pyxis, and the consumma-
tion of the transactions contemplated thereby, will not breach,
violate or conflict with any instrument or agreement governing
or contained within any of the Intellectual Property, will not
cause the forfeiture or termination or give rise to a right of
forfeiture or termination of any of the Intellectual Property
or in any way impair the right of Cardinal or Subcorp to use,
sell, license or dispose of, or to bring any action for the
infringement of, any Intellectual Property; (xiv) there are no
royalties, honoraria, fees or other payments payable to any
third party by reason of the ownership, use, license, sale or
disposition of the Intellectual Property; (xv) no part of the
source or object code, algorithms or structure included in any
of the Intellectual Property is copied from, based upon, or
derived from any source or object code, algorithm or structure
included in any computer software product owned by any third
party nor does any substantial similarity of any of such source
-21-<PAGE>
or object code, algorithms or structure to any computer soft-
ware product owned by any third party result from such source
or object code, algorithms or structure being copied from,
based upon or derived from any computer software product owned
by any third party; and (xvi) no software included in the In-
tellectual Property contains any "Self-Help Code," i.e., any
back door, time bomb, drop dead device, or other software rou-
tine designed to disable a computer program automatically with
the passage of time or under the positive control of any unau-
thorized person, or, to Pyxis's knowledge, any "Unauthorized
Code," i.e., any virus, Trojan horse, worm, or other software
routines or hardware components designed to permit unauthorized
access, disable, erase, or otherwise harm software, hardware,
or data or to perform any other such actions.
(b) Pyxis has taken all steps that are reasonably
necessary and appropriate to safeguard and maintain the secrecy
and confidentiality of all trade secrets contained in the
Intellectual Property (including, without limitation, entering
into appropriate confidentiality, nondisclosure and non-
competition agreements with all officers, directors, employees
and third-party consultants of Pyxis.
(c) Pyxis has taken all steps that are reasonably
necessary and appropriate to safeguard and maintain all
copyrights and patents contained in the Intellectual Property,
including, without limitation, entering into appropriate
assignments with all current and former officers, directors,
employees and third party consultants of Pyxis.
4.11 Title to and Condition of Properties. Pyxis
owns or holds under valid leases all real property, plants,
machinery and equipment necessary for the conduct of the busi-
ness of Pyxis as presently conducted, except where the failure
to own or hold such property, plants, machinery and equipment
would not have a material adverse effect on Pyxis. Section
4.11 to the Pyxis Disclosure Schedule lists, and Pyxis has fur-
nished or made available to Cardinal, copies of all third party
environmental or other reports prepared by or for Pyxis with
respect to the real property owned, leased or used by Pyxis.
4.12 Registration Statement. None of the informa-
tion provided by Pyxis for inclusion in the Registration State-
ment at the time it becomes effective or, in the case of the
Joint Proxy Statement, at the date of mailing, will contain any
untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to
make the statements therein, in light of the circumstances un-
der which they were made, not misleading. The Registration
Statement and Joint Proxy Statement, except for such portions
-22-<PAGE>
thereof that relate only to Cardinal and its subsidiaries, will
each comply as to form in all material respects with the provi-
sions of the Securities Act and the Exchange Act.
4.13 Litigation. Except as set forth in Section
4.13 to the Pyxis Disclosure Schedule, there is no Action
pending or, to the knowledge of Pyxis, threatened against Pyxis
which, individually or in the aggregate, could reasonably be
expected to have a material adverse effect on Pyxis or a
material adverse effect on the ability of Pyxis to consummate
the transactions contemplated hereby. Pyxis is not subject to
any outstanding order, writ, injunction or decree which,
individually or in the aggregate, insofar as can be reasonably
foreseen, could have a material adverse effect on Pyxis or a
material adverse effect on the ability of Pyxis to consummate
the transactions contemplated hereby. Except as set forth in
Section 4.13 to the Pyxis Disclosure Schedule, since December
31, 1992, Pyxis has not been subject to any outstanding order,
writ, injunction or decree relating to Pyxis's method of doing
business or its relationship with past, existing or future
lessees, users, purchasers or licensees of any Intellectual
Property, goods or services of Pyxis.
4.14 Brokerage and Finder's Fees; Expenses. Except
for Pyxis's obligations to Donaldson, Lufkin & Jenrette Securi-
ties Corporation ("DLJ") (a copy of the written agreement re-
lating to such obligations having previously been provided to
Cardinal), neither Pyxis nor any stockholder, director, officer
or employee thereof, has incurred or will incur on behalf of
Pyxis, any brokerage, finder's or similar fee in connection
with the transactions contemplated by this Agreement. Section
4.14 to the Pyxis Disclosure Schedule discloses a bona fide
estimate of the aggregate amount of all fees and expenses ex-
pected to be paid by Pyxis to all attorneys, accountants and
investment bankers in connection with the Merger ("Merger
Fees").
4.15 Accounting Matters. Neither Pyxis nor any of
its affiliates has taken or agreed to take any action that
(without giving effect to any actions taken or agreed to be
taken by Cardinal or any of its affiliates) would prevent
Cardinal from accounting for the business combination to be ef-
fected by the Merger as a pooling-of-interests for financial
reporting purposes. None of the transactions contemplated by
this Agreement, including, without limitation, any transaction
or agreement entered into pursuant to Section 5.3(e) or Section
5.3(h) or otherwise permitted by Section 5.3(c) will prevent
Cardinal from accounting for the business combination to be
affected by the Merger as a pooling-of-interests for financial
reporting purposes.
-23-<PAGE>
4.16 Employee Benefit Plans.
(a) For purposes of this Section 4.16, the following
terms have the definitions given below:
"Controlled Group Liability" means any and all
liabilities under (i) Title IV of ERISA, (ii) section
302 of ERISA, (iii) sections 412 and 4971 of the
Code, (iv) the continuation coverage requirements of
section 601 et seq. of ERISA and section 4980B of the
Code, and (v) corresponding or similar provisions of
foreign laws or regulations, in each case other than
pursuant to the Plans.
"ERISA" means the Employee Retirement Income
Security Act of 1974, as amended, and the regulations
thereunder.
"ERISA Affiliate" means, with respect to any
entity, trade or business, any other entity, trade or
business that is a member of a group described in
Section 414(b), (c), (m) or (o) of the Code or Sec-
tion 4001(b)(1) of ERISA that includes the first en-
tity, trade or business, or that is a member of the
same "controlled group" as the first entity, trade or
business pursuant to Section 4001(a)(14) of ERISA.
"Plans" means all employee benefit plans, pro-
grams, policies, practices, and other arrangements
providing benefits to any employee or former employee
or beneficiary or dependent thereof, whether or not
written, and whether covering one person or more than
one person, sponsored or maintained by Pyxis or any
of its subsidiaries or to which Pyxis or any of its
subsidiaries contributes or is obligated to contrib-
ute. Without limiting the generality of the forego-
ing, the term "Plans" includes all employee welfare
benefit plans within the meaning of Section 3(1) of
ERISA and all employee pension benefit plans within
the meaning of Section 3(2) of ERISA.
(b) Section 4.16 to the Pyxis Disclosure Schedule
lists all Plans. With respect to each Plan, Pyxis has made
available to Cardinal a true, correct and complete copy of:
(i) each writing constituting a part of such Plan, including
without limitation all plan documents, benefit schedules, trust
agreements, and insurance contracts and other funding vehicles;
(ii) the most recent Annual Report (Form 5500 Series) and ac-
companying schedule, if any; (iii) the current summary plan
-24-<PAGE>
description, if any; (iv) the most recent annual financial re-
port, if any; and (v) the most recent determination letter from
the IRS, if any.
(c) The Internal Revenue Service has issued a favor-
able determination letter with respect to each Plan that is
intended to be a "qualified plan" within the meaning of Section
401(a) of the Code (a "Qualified Plan") and there are no exist-
ing circumstances nor any events that have occurred that could
adversely affect the qualified status of any Qualified Plan the
related trust.
(d) All contributions required to be made to any
Plan by Applicable Laws or by any plan document or other con-
tractual undertaking, and all premiums due or payable with re-
spect to insurance policies funding any Plan, for any period
through the date hereof have been timely made or paid in full
and through the Closing Date will be timely made or paid in
full or, to the extent not required to be made or paid on or
before the date hereof or the Closing Date, as applicable, have
been or will be fully reflected in the Pyxis SEC Documents
filed or to be filed with the Commission.
(e) Pyxis and its subsidiaries have complied, and
are now in compliance, in all material respects, with all pro-
visions of ERISA, the Code and all laws and regulations ap-
plicable to the Plans. There is not now, and there are no ex-
isting, circumstances that could give rise to, any requirement
for the posting of security with respect to a Plan or the impo-
sition of any lien on the assets of Pyxis or any of its subsid-
iaries under ERISA or the Code.
(f) No Plan is subject to Title IV or Section 302 of
ERISA or Section 412 or 4971 of the Code. No Plan is a "multi-
employer plan" within the meaning of Section 4001(a)(3) of
ERISA (a "Multiemployer Plan") or a plan that has two or more
contributing sponsors at least two of whom are not under common
control, within the meaning of Section 4063 of ERISA (a "Mul-
tiple Employer Plan"), nor has Pyxis or any of its subsidiaries
or any of their respective ERISA Affiliates, at any time within
five years before the date hereof, contributed to or been obli-
gated to contribute to any Multiemployer Plan or Multiple Em-
ployer Plan.
(g) There does not now exist, and there are no ex-
isting, circumstances that could result in, any Controlled
Group Liability that would be a liability of Pyxis or any of
its subsidiaries following the Closing. Without limiting the
-25-<PAGE>
generality of the foregoing, neither Pyxis nor any of its sub-
sidiaries nor any of their respective ERISA Affiliates has en-
gaged in any transaction described in Section 4069 or Section
4204 of ERISA.
(h) Except for health continuation coverage as re-
quired by Section 4980B of the Code or Part 6 of Title I of
ERISA, neither Pyxis nor any of its subsidiaries has any li-
ability for life, health, medical or other welfare benefits to
former employees or beneficiaries or dependents thereof.
(i) Except as set forth in Section 4.16(i) to the
Pyxis Disclosure Schedule, neither the execution and delivery
of this Agreement nor the consummation of the transactions con-
templated hereby will result in, cause the accelerated vesting
or delivery of, or increase the amount or value of, any payment
or benefit to any employee of Pyxis or any of its subsidiaries.
Without limiting the generality of the foregoing and except as
set forth in Section 4.16(i) to the Pyxis Disclosure Schedule,
no amount paid or payable by Pyxis or any of its subsidiaries
in connection with the transactions contemplated hereby will be
an "excess parachute payment" within the meaning of Section
280G of the Code.
(j) There are no pending or threatened claims (other
than claims for benefits in the ordinary course), lawsuits or
arbitrations which have been asserted or instituted against the
Employee Plans, any fiduciaries thereof with respect to their
duties to the Employee Plans or the assets of any of the trusts
under any of the Employee Plans which could reasonably be ex-
pected to result in any material liability of Pyxis or any of
its subsidiaries to the Pension Benefit Guaranty Corporation,
the Department of Treasury, the Department of Labor or any mul-
tiemployer plan.
(k) Section 4.16(k) to the Pyxis Disclosure Schedule
sets forth the names of all directors and officers of Pyxis,
the total salary, bonus, fringe benefits and perquisites each
received in the fiscal year ended December 31, 1995, and any
changes to the foregoing which have occurred subsequent to De-
cember 31, 1995; Section 4.16(k) to the Pyxis Disclosure
Schedule also lists and describes the current compensation of
any other employee of Pyxis whose total current salary and max-
imum bonus opportunity exceeds $100,000 annually. Except as
disclosed in Section 4.16(k) to the Pyxis Disclosure Schedule
or in Pyxis's 1994 Proxy Statement, there are no other material
forms of compensation paid to any such director, officer or
employee of Pyxis. Except as set forth in Section 4.16(k) to
-26-<PAGE>
the Pyxis Disclosure Schedule, no officer, director, or em-
ployee of Pyxis or any other affiliate of Pyxis, or any immedi-
ate family member of any of the foregoing, provides or causes
to be provided to Pyxis any material assets, services or fa-
cilities and Pyxis does not provide or cause to be provided to
any such officer, director, employee or affiliate, or any im-
mediate family member of any of the foregoing, any material
assets, services or facilities.
4.17 Contracts. Section 4.17 to the Pyxis Disclo-
sure Schedule lists all written or oral contracts, agreements,
guarantees, leases and executory commitments (each a "Con-
tract") to which Pyxis is a party and which fall within any of
the following categories: (a) Contracts not entered into in the
ordinary course of Pyxis's business, (b) joint venture, part-
nership and like agreements, (c) Contracts which are service
contracts (excluding contracts for delivery services entered
into in the ordinary course of business) or equipment leases
involving payments by Pyxis of more than $200,000 per year, (d)
Contracts containing covenants purporting to limit the freedom
of Pyxis to compete in any line of business in any geographic
area or to hire any individual or group of individuals, (e)
Contracts which after the Effective Time would have the effect
of limiting the freedom of Cardinal or its subsidiaries (other
than Pyxis and its subsidiaries) to compete in any line of bus-
iness in any geographic area or to hire any individual or group
of individuals, (f) Contracts which contain minimum purchase
conditions or requirements or other terms that restrict or
limit the purchasing relationships of Pyxis or any lessee
thereof, (g) Contracts relating to any outstanding commitment
for capital expenditures in excess of $100,000, (h) Contracts
relating to the lease or sublease of or sale or purchase of
real or personal property involving any annual expense or price
in excess of $100,000 and not cancellable by Pyxis (without
premium or penalty) within one month, (i) Contracts with any
labor organization, (j) indentures, mortgages, promissory
notes, loan agreements, guarantees of amounts in excess of
$100,000, letters of credit or other agreements or instruments
of Pyxis or commitments for the borrowing or the lending of
amounts in excess of $100,000 or by Pyxis or providing for the
creation of any charge, security interest, encumbrance or lien
upon any of the assets of Pyxis, (k) Contracts involving annual
revenues or expenditures to the business of Pyxis in excess of
2.0% of Pyxis's annual revenues (other than lease agreements
with customers) and (l) Contracts with or for the benefit of
any affiliate of Pyxis or immediate family member thereof
(other than subsidiaries of Pyxis). All such Contracts are
valid and binding obligations of Pyxis and, to the knowledge of
Pyxis, the valid and binding obligation of each other party
thereto except such Contracts which if not so valid and binding
-27-<PAGE>
would not, individually or in the aggregate, have a material
adverse effect on Pyxis. Neither Pyxis nor, to the knowledge
of Pyxis, any other party thereto is in violation of or in de-
fault in respect of, nor has there occurred an event or condi-
tion which with the passage of time or giving of notice (or
both) would constitute a default under, any such Contract ex-
cept such violations or defaults under such Contracts which,
individually or in the aggregate, would not have a material
adverse effect on Pyxis.
4.18 Accounts Receivable. All accounts and notes
receivable (including lease and finance notes receivable) and
accrued interest receivable of Pyxis have arisen in the ordi-
nary course of business and the accounts receivable reserves
reflected on the balance sheet as of September 30, 1995 in-
cluded in the Pyxis SEC Documents are as of such date estab-
lished in accordance with generally accepted accounting prin-
ciples consistently applied and to the best knowledge of Pyxis
will be collectible in an amount not less than the amounts
thereof carried on the balance sheet as of such date included
in the Pyxis SEC Documents, net of any reserves included
thereon, as applicable, except for any uncollectable amount
which, individually or in the aggregate, would not have a mate-
rial adverse effect on Pyxis.
4.19 Labor Relations. There is no unfair labor
practice complaint against Pyxis pending before the NLRB and
there is no labor strike, dispute, slowdown or stoppage, or any
union organizing campaign, actually pending or, to the knowl-
edge of Pyxis, threatened against or involving Pyxis.
4.20 Undisclosed Liabilities. Except (i) as and to
the extent disclosed or reserved against on the balance sheet
of Pyxis as of September 30, 1995 included in the Pyxis SEC
Documents, (ii) as incurred after the date thereof in the ordi-
nary course of business consistent with prior practice and not
prohibited by this Agreement or (iii) as set forth in Section
4.20 to the Pyxis Disclosure Schedule, Pyxis does not have any
liabilities or obligations of any nature, whether known or un-
known, absolute, accrued, contingent or otherwise and whether
due or to become due, that, individually or in the aggregate,
have or could reasonably be expected to have a material adverse
effect on Pyxis.
4.21 Operation of Pyxis's Business; Relationships.
(a) Since September 30, 1995 through the date of this Agree-
ment, Pyxis has not engaged in any transaction which, if done
after execution of this Agreement, would violate Section 5.3(c)
hereof except as described or reflected in the Pyxis SEC Docu-
ments or as set forth in Section 4.21 to the Pyxis Disclosure
-28-<PAGE>
Schedule. Section 4.21 to the Pyxis Disclosure Schedule de-
scribes each termination or nonrenewal that has occurred with
respect to any Contract with any lessee or licensee of Intel-
lectual Property, from December 31, 1994 to the date hereof.
(b) The relationships of Pyxis with its customers
and suppliers are satisfactory and the execution of this Agree-
ment, the Merger and the transactions contemplated hereby will
not materially adversely affect the relationships of Pyxis with
such customers or suppliers.
(c) No product produced by Pyxis or produced for
Pyxis by a third party and bearing an Pyxis trademark or other
Proprietary Right of Pyxis, has been recalled voluntarily or
involuntarily since December 31, 1992, no such recall is being
considered by Pyxis, and, to the knowledge of Pyxis, no such
recall is being considered by or has been requested or ordered
by any Governmental Authority or consumer group.
4.22 Permits; Compliance. Pyxis is in possession of
all franchises, grants, authorizations, licenses, permits,
easements, variances, exemptions, consents, certificates, ap-
provals and orders necessary to own, lease and operate its
properties and to carry on its business as it is now being con-
ducted other than those which are immaterial (collectively, the
"Pyxis Permits"), and there is no Action pending or, to the
knowledge of Pyxis, threatened regarding suspension or cancel-
lation of any of the Pyxis Permits, except for any such Action
which, if determined adversely, could not reasonably be ex-
pected, individually or in the aggregate, to have a material
adverse effect on Pyxis. Pyxis is not in conflict with, or in
default or violation of, any of the Pyxis Permits, except for
any such conflicts, defaults or violations which, individually
or in the aggregate, could not reasonably be expected to have a
material adverse effect on Pyxis. During the period commencing
on December 31, 1992 and ending on the date hereof, Pyxis has
not received any notification with respect to possible con-
flicts, defaults or violations of Applicable Laws, except for
notices relating to possible conflicts, defaults or violations,
which conflicts, defaults or violations could not reasonably be
expected to have a material adverse effect on Pyxis.
4.23 Product Warranties and Liabilities. Except as
listed in Section 4.23 to the Pyxis Disclosure Schedule, Pyxis
has no forms of warranties or guarantees of its products and
services that are in effect or proposed to be used by it. Sec-
tion 4.23 to the Pyxis Disclosure Schedule sets forth a de-
scription of each pending or, to the knowledge of Pyxis,
threatened material Action under any warranty or guaranty
against Pyxis. Pyxis has not incurred, nor does Pyxis know or
-29-<PAGE>
have any reason to believe there is any basis for alleging, any
material liability, damage, loss, cost or expense as a result
of any material defect or other deficiency (whether of design,
materials, workmanship, labeling instructions or otherwise)
("Product Liability") with respect to any product sold or
services rendered by or on behalf of Pyxis (including any les-
see thereof) prior to the Effective Time, whether such Product
Liability is incurred by reason of any express or implied war-
ranty (including, without limitation, any warranty of merchant-
ability or fitness), any doctrine of common law (tort, contract
or other), any statutory provision or otherwise and irrespec-
tive of whether such Product Liability is covered by insurance.
4.24 Environmental Matters.
(a) As used herein, the term "Environmental Laws"
means all federal, state, local or foreign laws relating to
pollution or protection of human health or the environment (in-
cluding, without limitation, ambient air, surface water,
groundwater, land surface or subsurface strata), including,
without limitation, laws relating to emissions, discharges,
releases or threatened releases of chemicals, pollutants, con-
taminants, or industrial, toxic or hazardous substances or
wastes (collectively, "Hazardous Materials") into the environ-
ment, or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or
handling of Hazardous Materials, as well as all authorizations,
codes, decrees, demands or demand letters, injunctions, judg-
ments, licenses, notices or notice letters, orders, permits,
plans or regulations issued, entered, promulgated or approved
thereunder.
(b) There are, with respect to Pyxis, its subsidiar-
ies or any predecessor of the foregoing, no past or present
material violations of Environmental Laws, releases of any ma-
terial into the environment, actions, activities, circum-
stances, conditions, events, incidents, or contractual obliga-
tions which may give rise to any common law environmental li-
ability or any liability under the Comprehensive Environmental
Response, Compensation and Liability Act of 1980 or similar
federal, state, local or foreign laws and none of Pyxis and its
subsidiaries has received any notice with respect to any of the
foregoing, nor is any Action pending or threatened in connec-
tion with any of the foregoing.
(c) No Hazardous Materials are contained on or about
any real property currently owned, leased or used by Pyxis or
any of its subsidiaries and no Hazardous Materials were re-
leased on or about any real property previously owned, leased
or used by Pyxis during the period the property was owned,
-30-<PAGE>
leased or used by Pyxis, except in the normal course of Pyxis's
business.
(d) There are no underground storage tanks on or
under any real property currently or previously owned, leased
or used by Pyxis or any of its subsidiaries.
4.25 Opinion of Financial Advisor. Pyxis has re-
ceived the written opinion of DLJ, its financial advisor, to
the effect that, as of February 6, 1996, the Exchange Ratio is
fair to the Pyxis Stockholders from a financial point of view,
Pyxis has heretofore provided a copy of such opinion to
Cardinal and such opinion has not been withdrawn, revoked or
modified.
4.26 Board Recommendation. The Board of Directors
of Pyxis, at a meeting duly called and held, has by unanimous
vote of those directors present (who constituted 100% of the
directors then in office) (i) determined that this Agreement
and the transactions contemplated hereby, including the Merger,
and the Stock Option Agreement and the transactions contem-
plated thereby, taken together, are fair to and in the best
interests of the stockholders of Pyxis, and (ii) resolved to
recommend that the holders of the shares of Pyxis Common Stock
approve this Agreement and the transactions contemplated
herein, including the Merger.
4.27 DGCL Section 203 and State Takeover Laws.
Prior to the date hereof, the Board of Directors of Pyxis has
taken all action necessary to exempt under or make not subject
to (x) Section 203 of the DGCL and (y) any other state takeover
law or state law that purports to limit or restrict business
combinations or the ability to acquire or vote shares: (i) the
execution of this Agreement, the Stock Option Agreement dated
February 7, 1996 between Cardinal and Pyxis (the "Stock Option
Agreement"), the Support/Voting Agreements dated as of February
7, 1996 between Cardinal and certain Pyxis Stockholders (col-
lectively, the "Support Agreements"), (ii) the Merger and (iii)
the transactions contemplated hereby and by the Stock Option
Agreement and the Support Agreements.
4.28 Lease Arrangements.
(a) Except as set forth in Section 4.28 to the Pyxis
Disclosure Schedule, there are no lessees ("Master Lessees")
who have been granted the right to use, purchase, lease or li-
cense Intellectual Property, goods or services from Pyxis and
to provide, resell, sublease or relicense same to other autho-
rized lessees or third parties. The identity of each Master
Lessee and a description of all lessees and third parties to
-31-<PAGE>
whom such Master Lessee is entitled to provide, resell, sub-
lease or relicense Intellectual Property, goods and services of
Pyxis are set forth in Section 4.28 to the Pyxis Disclosure
Schedule. There are no agreements between Pyxis and any Master
Lessee other than those in writing that are set forth in Sec-
tion 4.28 to the Pyxis Disclosure Schedule.
(b) The relationships of Pyxis with its lessees are
satisfactory, and to the best knowledge of Pyxis the execution
of this Agreement, the consummation of the Merger, and the
consummation of the transactions contemplated thereby will not
materially adversely affect the relationships of Pyxis with
such lessees.
(c) All property (personal or other) that is subject
to any "Rental Agreement" (as defined in the Vendor Program
Agreement, dated as of October 10, 1991, between General Elec-
tric Capital Corporation ("GE Capital") and Pyxis (together
with all riders, supplements and amendments thereto, the "Fi-
nancing Agreement")) sold and/or assigned to GE Capital under
the Financing Agreement (or any other similar type of agree-
ment) shall, upon expiration of the term of such Rental Agree-
ment, be owned by Pyxis free and clear of any liens, security
interests, encumbrances and restrictions of any kind.
4.29 [Intentionally Omitted]
4.30 Pyxis Rights Agreement. The Rights Agreement
dated as of August 5, 1994, between Pyxis and First Interstate
Bank (the "Rights Agreement"), has been amended, and will re-
main amended (and no replacement plan will be adopted), so as
to provide that none of Cardinal and its affiliates will become
an "Acquiring Person" and that no "Stock Acquisition Date" or
"Distribution Date" (as such terms are defined in the Rights
Agreement) will occur as a result of the execution of this
Agreement or the Stock Option Agreement or the consummation of
the Merger pursuant to this Agreement or the acquisition or
transfer of shares of Pyxis Common Stock by Cardinal pursuant
to the Stock Option Agreement.
ARTICLE V
COVENANTS OF THE PARTIES
The parties hereto agree as follows with respect to
the period from and after the execution of this Agreement.
-32-<PAGE>
5.1 Mutual Covenants.
(a) General. Each of the parties shall use its rea-
sonable efforts to take all action and to do all things neces-
sary, proper or advisable to consummate the Merger and the
transactions contemplated by this Agreement (including, without
limitation, using its reasonable efforts to cause the condi-
tions set forth in Article VI for which they are responsible to
be satisfied as soon as reasonably practicable and to prepare,
execute and deliver such further instruments and take or cause
to be taken such other and further action as any other party
hereto shall reasonably request).
(b) HSR Act. As soon as practicable, and in any
event no later than ten (10) business days after the date here-
of, each of the parties hereto will file any Notification and
Report Forms and related material required to be filed by it
with the Federal Trade Commission and the Antitrust Division of
the United States Department of Justice under the HSR Act with
respect to the Merger, will use its reasonable efforts to ob-
tain an early termination of the applicable waiting period, and
shall promptly make any further filings pursuant thereto that
may be necessary, proper or advisable; provided, however, that
neither Cardinal nor any of its subsidiaries shall be required
hereunder to divest or hold separate any portion of their busi-
ness or assets.
(c) Other Governmental Matters. Each of the parties
shall use its reasonable efforts to take any additional action
that may be necessary, proper or advisable in connection with
any other notices to, filings with, and authorizations, con-
sents and approvals of any Governmental Authority that it may
be required to give, make or obtain.
(d) Pooling-of-Interests. Each of the parties shall
use its best efforts to cause the Merger to qualify for
pooling-of-interests accounting treatment for financial report-
ing purposes.
(e) Tax-Free Treatment. Each of the parties shall
use its best efforts to cause the Merger to constitute a tax-
free "reorganization" under Section 368(a) of the Code and to
permit Pillsbury Madison & Sutro LLP to issue its opinion pro-
vided for in Section 6.1(f).
(f) Public Announcements. Unless otherwise required
by Applicable Laws or requirements of the National Association
of Securities Dealers or the NYSE (and in that event only if
time does not permit), at all times prior to the earlier of the
Effective Time or termination of this Agreement pursuant to
-33-<PAGE>
Section 7.1, Cardinal and Pyxis shall consult with each other
before issuing any press release with respect to the Merger and
shall not issue any such press release prior to such consulta-
tion.
(g) Access. From and after the date of this Agree-
ment until the Effective Time (or the termination of this
Agreement), Cardinal and Pyxis shall permit representatives of
the other to have appropriate access at all reasonable times to
the other's premises, properties, books, records, contracts,
tax records, documents, customers and suppliers. Information
obtained by Cardinal and Pyxis pursuant to this Section 5.1(g)
shall be subject to the provisions of the confidentiality
agreement between them dated November 30, 1995 (the "Confiden-
tiality Agreement"), which agreement remains in full force and
effect.
(h) Directors' and Officers' Insurance. Cardinal
and Pyxis shall collaborate in good faith to use their
respective efforts to cause the Surviving Corporation to obtain
and maintain in effect after the Effective Time policies of
directors' and officers' liability insurance at no cost to the
beneficiaries thereof with respect to acts or omissions
occurring prior to the Effective Time with substantially the
same coverage and containing substantially similar terms and
conditions as existing policies; provided, however, that the
Surviving Corporation shall not be required to pay an aggregate
premium for such insurance coverage in excess of the amount set
forth in Section 5.1(h) to the Pyxis Disclosure Schedule, but
in any event shall purchase as much coverage as possible for
such amount on terms reasonably acceptable to Pyxis.
5.2 Covenants of Cardinal.
(a) Cardinal Shareholders Meeting. Cardinal shall
take all action in accordance with the federal securities laws,
the Ohio Revised Code and the Cardinal Articles and Code of
Regulations, as amended and restated, necessary to obtain the
consent and approval of Cardinal Shareholders with respect to
the authorization of the issuance of Cardinal Common Shares in
the Merger and the transactions contemplated hereby.
(b) Preparation of Joint Proxy Statement. Cardinal
shall, as soon as is reasonably practicable, prepare and file
the Joint Proxy Statement with the Commission on a confidential
basis. Cardinal shall prepare and file the Registration State-
ment with the Commission as soon as is reasonably practicable
following clearance of the Joint Proxy Statement by the Commis-
sion and shall use all reasonable efforts to have the Registra-
tion Statement declared effective by the Commission as promptly
-34-<PAGE>
as practicable and to maintain the effectiveness of the Regis-
tration Statement through the Effective Time. Cardinal shall
use all reasonable efforts to mail at the earliest practicable
date to Cardinal Shareholders the Joint Proxy Statement, which
shall include all information required under Applicable Law to
be furnished to Cardinal Shareholders in connection with the
Merger and the transactions contemplated thereby. Cardinal
also shall take such other reasonable actions (other than
qualifying to do business in any jurisdiction in which it is
not so qualified) required to be taken under any applicable
state securities laws in connection with the issuance of
Cardinal Common Shares in the Merger.
(c) Conduct of Cardinal's Operations. During the
period from the date of this Agreement to the Effective Time,
Cardinal shall use its reasonable efforts to maintain and pre-
serve its business organization and to retain the services of
its officers and key employees and maintain relationships with
customers, suppliers and other third parties to the end that
their goodwill and ongoing business shall not be impaired in
any material respect.
(d) Indemnification. From and after the Effective
Time, Cardinal shall cause the Surviving Corporation
(including, to the extent required, providing sufficient
funding) to (i) indemnify and hold harmless the present and
former officers and directors of Pyxis in respect of acts or
omissions occurring prior to the Effective Time to the extent
provided under the Pyxis Certificate of Incorporation, as
amended and restated, and Bylaws in effect on the date hereof
and (ii) perform and fulfill all of its obligations under the
Indemnification Agreements between Pyxis and the persons listed
in Section 5.2(d) of the Pyxis Disclosure Schedule and in
effect as of the date hereof.
(e) Employee Benefits. Cardinal covenants and
agrees that, for a period of one year from and after the Ef-
fective Time, it will cause the Surviving Corporation to pro-
vide for the benefit of employees of the Surviving Corporation
benefits that are no less favorable, in the aggregate, as those
provided to employees of Pyxis immediately prior to the date of
this Agreement.
(f) Notification of Certain Matters. Cardinal shall
give prompt notice to Pyxis of (i) the occurrence or non-
occurrence of any event the occurrence or non-occurrence of
which would cause any Cardinal or Subcorp representation or
warranty contained in this Agreement to be untrue or inaccurate
at or prior to the Effective Time and (ii) any material failure
of Cardinal to comply with or satisfy any covenant, condition
-35-<PAGE>
or agreement to be complied with or satisfied by it hereunder;
provided, however, that the delivery of any notice pursuant to
this Section 5.2(f) shall not limit or otherwise affect the
remedies available hereunder to Pyxis.
5.3 Covenants of Pyxis.
(a) Pyxis Stockholders Meeting. Pyxis shall take
all action in accordance with the federal securities laws, the
DGCL and its Certificate of Incorporation, as amended and re-
stated, and Bylaws necessary to obtain the consent and approval
of Pyxis Stockholders with respect to the Merger, this Agree-
ment and the transactions contemplated hereby.
(b) Information for the Registration Statement and
Preparation of Joint Proxy Statement. Pyxis shall promptly
furnish Cardinal with all information concerning it as may be
required for inclusion in the Registration Statement. Pyxis
shall cooperate with Cardinal in the preparation of the Regis-
tration Statement in a timely fashion and shall use all reason-
able efforts to assist Cardinal in having the Registration
Statement declared effective by the Commission as promptly as
practicable. If at any time prior to the Effective Time, any
information pertaining to Pyxis contained in or omitted from
the Registration Statement makes such statements contained in
the Registration Statement false or misleading, Pyxis shall
promptly so inform Cardinal and provide Cardinal with the
information necessary to make statements contained therein not
false and misleading. Pyxis shall use all reasonable efforts
to cooperate with Cardinal in the preparation and filing of the
Joint Proxy Statement with the Commission on a confidential
basis. Pyxis shall use all reasonable efforts to mail at the
earliest practicable date to Pyxis Stockholders the Joint Proxy
Statement, which shall include all information required under
Applicable Law to be furnished to Pyxis Stockholders in connec-
tion with the Merger and the transactions contemplated thereby
and shall include the recommendation of Pyxis's Board of Direc-
tors in favor of the Merger unless the Pyxis Board of Directors
concludes in good faith on the basis of the advice of its out-
side counsel that the failure to withdraw such recommendation
would violate the fiduciary obligations of the Board of Direc-
tors under Applicable Law.
(c) Conduct of Pyxis's Operations. During the pe-
riod from the date of this Agreement to the Effective Time,
Pyxis shall conduct its operations in the ordinary course ex-
cept as expressly contemplated by this Agreement and the trans-
actions contemplated hereby and shall use its reasonable ef-
forts to maintain and preserve its business organization and
its material rights and franchises and to retain the services
-36-<PAGE>
of its officers and key employees and maintain relationships
with customers, suppliers, lessees, Master Lessees, licensees
and other third parties to the end that their goodwill and on-
going business shall not be impaired in any material respect.
Without limiting the generality of the foregoing, during the
period from the date of this Agreement to the Effective Time,
Pyxis shall not, except as otherwise expressly contemplated by
this Agreement and the transactions contemplated hereby or as
set forth in Section 5.3(c) to the Pyxis Disclosure Schedule,
without the prior written consent of Cardinal:
(i) do or effect any of the following actions with
respect to its securities: (A) adjust, split, combine or
reclassify its capital stock, (B) make, declare or pay any
dividend or distribution on, or directly or indirectly
redeem, purchase or otherwise acquire, any shares of its
capital stock or any securities or obligations convertible
into or exchangeable for any shares of its capital stock,
(C) grant any person any right or option to acquire any
shares of its capital stock, (D) issue, deliver or sell or
agree to issue, deliver or sell any additional shares of
its capital stock or any securities or obligations con-
vertible into or exchangeable or exercisable for any
shares of its capital stock or such securities (except
pursuant to the exercise of outstanding options to pur-
chase Pyxis Common Stock), or (E) enter into any agree-
ment, understanding or arrangement with respect to the
sale or voting of its capital stock;
(ii) except to the extent set forth in Section 5.3(c)
of the Pyxis Disclosure Schedule, sell, transfer, lease,
pledge, mortgage, encumber or otherwise dispose of any of
its property or assets other than sales or leases of in-
ventory or licensing of Intellectual Property made in the
ordinary course of business;
(iii) make or propose any changes in its Certificate
of Incorporation, as amended and restated, or Bylaws;
(iv) merge or consolidate with any other person or
acquire a material amount of assets or capital stock of
any other person or, except to the extent permitted under
Section 5.3(e), enter into any confidentiality agreement
with any person;
(v) incur, create, assume or otherwise become liable
for indebtedness in excess of $25,000 for borrowed money
or assume, guarantee, endorse or otherwise as an accom-
modation become responsible or liable for obligations in
-37-<PAGE>
excess of $25,000 of any other individual, corporation or
other entity;
(vi) create any subsidiaries;
(vii) enter into or modify any employment, severance,
termination or similar agreements or arrangements with, or
grant any bonuses, salary increases, severance or termina-
tion pay to, any officer, director, consultant or employee
other than salary increases granted in the ordinary course
of business consistent with past practice to employees who
are not officers or directors of Pyxis, or otherwise in-
crease the compensation or benefits provided to any of-
ficer, director, consultant or employee except as may be
required by Applicable Law or a binding written contract
in effect on the date of this Agreement;
(viii) change its method of doing business or change
any method or principle of accounting in a manner that is
inconsistent with past practice;
(ix) settle any Actions, whether now pending or here-
after made or brought involving an amount in excess of
$50,000;
(x) modify, amend or terminate, or waive, release or
assign any material rights or claims with respect to, any
Contract set forth in Section 4.17 to the Pyxis Disclosure
Schedule, any other material Contract to which Pyxis is a
party or any confidentiality agreement to which Pyxis is a
party;
(xi) incur or commit to any capital expenditures,
obligations or liabilities in respect thereof which in the
aggregate exceed or would exceed $100,000;
(xii) make any payments in respect of policies of di-
rectors' and officers' liability insurance (premiums or
otherwise) other than premiums paid in respect of its cur-
rent policies on a month-to-month basis not in excess of
one-twelfth of the amount set forth in Section 5.1(h) to
the Pyxis Disclosure Schedule;
(xiii) make any material changes or modifications to
any pricing policy (including lease rates and related dis-
counts or fees) or investment policy or enter into any new
leases or Master Lessee relationship on terms different
from those in effect in the ordinary and usual course of
business, consistent with past practice;
-38-<PAGE>
(xiv) pay (or agree to become obligated to pay) any
Merger Fees in excess of the amount set forth in Section
4.14 to the Pyxis Disclosure Schedule, other than any ex-
cess amounts which are immaterial in the aggregate in-
curred in connection with and in furtherance of consumma-
tion of the transactions contemplated hereby;
(xv) take any action to exempt or make not subject to
(x) Section 203 of the DGCL or (y) any other state take-
over law or state law that purports to limit or restrict
business combinations or the ability to acquire or vote
shares, any person or entity (other than Cardinal or its
subsidiaries) or any action taken thereby, which person,
entity or action would have otherwise been subject to the
restrictive provisions thereof and not exempt therefrom,
in each case, unless the Pyxis Board of Directors con-
cludes in good faith on the basis of the advice of its
outside counsel, that the failure to take such action
would violate the fiduciary obligations of the Board of
Directors under Applicable Law;
(xvi) take any action that could result in the repre-
sentations and warranties set forth in Section 4.30 becom-
ing false or inaccurate, or, unless the Pyxis Board of
Directors concludes in good faith on the basis of the ad-
vice of its outside counsel, that the failure to take such
action would violate the fiduciary obligations of the
Board of Directors under Applicable Law, to otherwise ter-
minate, amend, modify or make inapplicable as to any per-
son or entity, or exempt any person from or take any ac-
tion that would qualify any tender or exchange offer as a
"Permitted Offer" under, the Rights Agreement or redeem
the rights issued thereunder;
(xvii) enter into or carry out any other transaction
other than in the ordinary and usual course of business;
(xviii) permit or cause any subsidiary to do any of the
foregoing or agree or commit to do any of the foregoing;
or
(xix) agree in writing or otherwise to take any of the
foregoing actions.
(d) Intellectual Property Matters. Pyxis shall use
its best efforts to preserve its ownership rights to the Intel-
lectual Property free and clear of any liens, claims or encum-
brances and shall use its best efforts to assert, contest and
prosecute any infringement of any issued foreign or domestic
patent, trademark, service mark, tradename or copyright that
-39-<PAGE>
forms a part of the Intellectual Property or any misappropria-
tion or disclosure of any trade secret, confidential informa-
tion or know-how that forms a part of the Intellectual Prop-
erty.
(e) No Solicitation. Pyxis agrees that, during the
term of this Agreement, it shall not, and shall not authorize
or permit any of its subsidiaries or any of its or its subsid-
iaries' directors, officers, employees, agents or representa-
tives, directly or indirectly, to solicit, initiate, encourage
or facilitate, or furnish or disclose non-public information in
furtherance of, any inquiries or the making of any proposal
with respect to any recapitalization, merger, consolidation or
other business combination involving Pyxis, or acquisition of
any capital stock (other than upon exercise of outstanding
Pyxis Options) or any material portion of the assets (except
for acquisition of assets in the ordinary course of business
consistent with past practice) of Pyxis, or any combination of
the foregoing (a "Competing Transaction"), or negotiate, ex-
plore or otherwise engage in discussions with any person (other
than Cardinal, Subcorp or their respective directors, officers,
employees, agents and representatives) with respect to any Com-
peting Transaction or enter into any agreement, arrangement or
understanding requiring it to abandon, terminate or fail to
consummate the Merger or any other transactions contemplated by
this Agreement; provided that Pyxis may furnish information to,
and negotiate or otherwise engage in discussions with, any
party who delivers a written proposal for a Competing Trans-
action if and so long as the Board or Directors of Pyxis deter-
mines in good faith by a majority vote, based upon advice of
its outside legal counsel, that failing to take such action
would constitute a breach of the fiduciary duties of the Board
and such a proposal is, based upon advice of DLJ (or any other
nationally recognized investment banking firm), more favorable
to Pyxis's Stockholders in the aggregate and from a financial
point of view than the transactions contemplated by this
Agreement (including any adjustment to the terms and conditions
of such transactions proposed by Cardinal in response to such
Competing Transaction), and in such case the Board of Directors
of Pyxis may withdraw its recommendation of this Agreement or
the Merger (provided that the foregoing shall in no way limit
or otherwise affect Cardinal's right to terminate this
Agreement pursuant to Section 7.1(e)). Pyxis will immediately
cease all existing activities, discussions and negotiations
with any parties conducted heretofore with respect to any of
the foregoing. From and after the execution of this Agreement,
Pyxis shall promptly advise Cardinal in writing of the receipt,
directly or indirectly, of any inquiries, discussions,
negotiations, or proposals relating to a Competing Transaction
(including the specific terms thereof) and promptly furnish to
-40-<PAGE>
Cardinal a copy of any such proposal or inquiry in addition to
any information provided to or by any third party relating
thereto.
(f) Affiliates of Pyxis. Pyxis shall cause each
such person who may be at the Effective Time or was on the date
hereof an "affiliate" of Pyxis for purposes of Rule 145 under
the Securities Act, to execute and deliver to Cardinal no less
than 35 days prior to the date of the meeting of Pyxis Stock-
holders to approve the Merger, the written undertakings in the
form attached hereto as Exhibit A. On or prior to such date,
Pyxis, with the advice of outside counsel, shall provide
Cardinal with a letter (reasonably satisfactory to counsel to
Cardinal) specifying all of the persons or entities who, may be
deemed to be "affiliates" of Pyxis under the preceding sen-
tence.
(g) Notification of Certain Matters. Pyxis shall
give prompt notice to Cardinal of (i) the occurrence or non-
occurrence of any event the occurrence or non-occurrence of
which would cause any Pyxis representation or warranty con-
tained in this Agreement to be untrue or inaccurate at or prior
to the Effective Time and (ii) any material failure of Pyxis to
comply with or satisfy any covenant, condition or agreement to
be complied with or satisfied by it hereunder; provided, how-
ever, that the delivery of any notice pursuant to this Section
5.3(g) shall not limit or otherwise affect the remedies avail-
able hereunder to Cardinal.
(h) Employment Agreements. Pyxis shall use its
reasonable best efforts to cause each employee of Pyxis set
forth in Section 5.3(h) to the Pyxis Disclosure Schedule to
enter into an employment agreement with Pyxis substantially in
the form attached to Section 5.3(h) to the Pyxis Disclosure
Schedule.
ARTICLE VI
CONDITIONS
6.1 Mutual Conditions. The obligations of the par-
ties hereto to consummate the Merger shall be subject to ful-
fillment of the following conditions:
-41-<PAGE>
(a) No temporary restraining order, preliminary or
permanent injunction or other order or decree which pre-
vents the consummation of the Merger shall have been is-
sued and remain in effect, and no statute, rule or regu-
lation shall have been enacted by any Governmental Author-
ity which prevents the consummation of the Merger.
(b) All waiting periods applicable to the consumma-
tion of the Merger under the HSR Act shall have expired or
been terminated.
(c) The Merger and the transactions contemplated
hereby shall have been approved by the Pyxis Stockholders
in the manner required by any Applicable Law.
(d) The issuance of the Cardinal Common Shares to be
issued in the Merger and the transactions contemplated
hereby shall have been approved by the Cardinal Sharehold-
ers in the manner required by any Applicable Law.
(e) The Commission shall have declared the Cardinal
Registration Statement effective. On the Closing Date and
at the Effective Time, no stop order or similar restrain-
ing order shall have been threatened by the Commission or
entered by the Commission or any state securities admin-
istrator prohibiting the Merger.
(f) Pyxis shall have received an opinion of Pills-
bury, Madison & Sutro LLP substantially to the effect
that, under Applicable Law, for Federal income tax pur-
poses, the Merger will constitute a reorganization under
Section 368 of the Code.
(g) Cardinal shall have received a letter, in form
and substance reasonably satisfactory to Cardinal, from
Deloitte & Touche L.L.P. dated the date of the Joint Proxy
Statement and confirmed in writing at the Effective Time
stating that the Merger will qualify as a pooling of in-
terests transaction under Opinion 16 of the Accounting
Principles Board.
(h) No Action shall be instituted by any Governmen-
tal Authority which seeks to prevent consummation of the
Merger or seeking material damages in connection with the
transactions contemplated hereby which continues to be
outstanding.
6.2 Conditions to Obligations of Pyxis. The obliga-
tions of Pyxis to consummate the Merger and the transactions
-42-<PAGE>
contemplated hereby shall be subject to the fulfillment of the
following conditions unless waived by Pyxis:
(a) The representations and warranties of each of
Cardinal and Subcorp set forth in Article III shall be
true and correct on the date hereof and on and as of the
Closing Date as though made on and as of the Closing Date
(except for representations and warranties made as of a
specified date, which need be true and correct only as of
the specified date), except for such inaccuracies which
have not had and would not reasonably be expected to have
in the reasonably foreseeable future a material adverse
effect on Cardinal.
(b) Each of Cardinal and Subcorp shall have per-
formed in all material respects each obligation and agree-
ment and shall have complied in all material respects with
each covenant to be performed and complied with by it
hereunder at or prior to the Effective Time.
(c) Each of Cardinal and Subcorp shall have fur-
nished Pyxis with a certificate dated the Closing Date
signed on behalf of it by the Chairman, President or any
Vice President to the effect that the conditions set forth
in Sections 6.2(a) and (b) have been satisfied.
(d) Pyxis shall have received the legal opinion,
dated the Closing Date, of Wachtell, Lipton, Rosen & Katz,
special counsel to Cardinal, in substantially the form at-
tached hereto as Exhibit B.
(e) The Cardinal Common Shares to be issued in the
Merger and the transactions contemplated hereby shall have
been authorized for inclusion on the NYSE, subject to of-
ficial notice of issuance.
(f) Since the date of this Agreement, except to the
extent contemplated by Section 3.11 to the Cardinal
Disclosure Schedule, there shall not have been any
material adverse change in the assets, liabilities,
results of operations, business or financial condition of
Cardinal and its subsidiaries taken as a whole or any ma-
terial adverse effect on the ability of Cardinal to
consummate the transactions contemplated hereby.
6.3 Conditions to Obligations of Cardinal and Sub-
corp. The obligations of Cardinal to consummate the Merger and
the other transactions contemplated hereby shall be subject to
the fulfillment of the following conditions unless waived by
each of Cardinal and Subcorp:
-43-<PAGE>
(a) The representations and warranties of Pyxis set
forth in (i) Article IV shall be true and correct on the
date hereof and on and as of the Closing Date as though
made on and as of the Closing Date (except for representa-
tions and warranties made as of a specified date, which
need be true and correct only as of the specified date),
except for such inaccuracies which have not had and would
not reasonably be expected to have in the reasonably fore-
seeable future a material adverse effect on Pyxis and (ii)
Section 4.28(b) and (c) shall be true and correct on the
date hereof and on and as of the Closing Date as though
made on and as of the Closing Date.
(b) Pyxis shall have performed in all material re-
spects each obligation and agreement and shall have com-
plied in all material respects with each covenant to be
performed and complied with by it hereunder at or prior to
the Effective Time.
(c) Pyxis shall have furnished Cardinal with a cer-
tificate dated the Closing Date signed on its behalf by
its Chairman, President or any Vice President to the ef-
fect that the conditions set forth in Sections 6.3(a) and
(b) have been satisfied.
(d) Cardinal shall have received the legal opinion,
dated the Closing Date, of Pillsbury Madison & Sutro LLP,
substantially in the form attached hereto as Exhibit C.
(e) Each person who may be at the Effective Time or
was on the date of this Agreement an "affiliate" of Pyxis
for purposes of Rule 145 under the Securities Act, shall
have executed and delivered to Cardinal at least 35 days
prior to the date of the meeting of Pyxis Stockholders to
approve the Merger the written undertakings in the form
attached hereto as Exhibit A.
(f) There shall not have been a breach of (i) any
obligation by any stockholder which has entered into a
Support Agreement or (ii) the Stock Option Agreement.
(g) Since the date of this Agreement, except to the
extent contemplated by Section 4.6 to the Pyxis Disclosure
Schedule, there shall not have been any material adverse
change in the assets, liabilities, results of operations,
business or financial condition of Pyxis and its subsid-
iaries taken as a whole or any material adverse effect on
the ability of Pyxis to consummate the transactions con-
templated hereby.
-44-<PAGE>
ARTICLE VII
TERMINATION AND AMENDMENT
7.1 Termination. This Agreement may be terminated
at any time prior to the Effective Time, whether before or af-
ter approval and adoption of this Agreement by Pyxis Stockhold-
ers and Cardinal Shareholders:
(a) by mutual consent of Cardinal and Pyxis;
(b) by either Cardinal or Pyxis if any permanent in-
junction or other order of a court or other competent Gov-
ernmental Authority preventing the consummation of the
Merger shall have become final and nonappealable;
(c) by either Cardinal or Pyxis if the Merger shall
not have been consummated before June 30, 1996, unless
extended by the Boards of Directors of both Cardinal and
Pyxis (provided that the right to terminate this Agreement
under this Section 7.1(c) shall not be available to any
party whose failure or whose affiliate's failure to per-
form any material covenant or obligation under this Agree-
ment has been the cause of or resulted in the failure of
the Merger to occur on or before such date);
(d) by either Cardinal or Pyxis, no earlier than the
fifth trading day nor later than the third full trading
day immediately preceding the earlier of (i) the meeting
of Pyxis Stockholders at which the vote to approve the
Merger occurs or (ii) the meeting of Cardinal Shareholders
at which the vote to approve and authorize the issuance of
Cardinal Common Shares in the Merger occurs, if the
Average Share Price is less than $55.34, provided that
Pyxis will have no right to terminate pursuant to this
paragraph (d) unless (x) Pyxis shall have given, during
the three trading day period set forth above, one full
trading day's prior written notice of its intention to
terminate pursuant to this Section 7.1(d) and (y) Cardinal
during such one full trading day notice period shall not
have given written notice (an "Adjustment Election") to
Pyxis that the Exchange Ratio shall be calculated pursuant
to clause (ii) of Section 2.2;
(e) by Cardinal if the Board of Directors of Pyxis
shall withdraw, modify or change its recommendation of
this Agreement or the Merger in a manner adverse to
Cardinal, or if the Board of Directors of Pyxis shall have
refused to affirm its recommendation within two business
-45-<PAGE>
days of any written request from Cardinal which request
was made upon a reasonable basis;
(f) by Cardinal or Pyxis if at the meeting of Pyxis
Stockholders (including any adjournment or postponement
thereof) the requisite vote of the Pyxis Stockholders to
approve the Merger and the transactions contemplated
hereby shall not have been obtained;
(g) by Cardinal or Pyxis if the authorization of the
Cardinal Shareholders with respect to the issuance of
Cardinal Common Shares in the Merger shall not have been
obtained by reason of the failure to obtain the required
vote at a meeting held for such purpose;
(h) by Cardinal if Pyxis shall have breached any of
its obligations under the Stock Option Agreement; or
(i) by Cardinal if at any time the representations
and warranties of Pyxis set forth in Section 4.15 shall
not be true and correct and Cardinal shall have been ad-
vised that the condition set forth in Section 6.1(g) can-
not be satisfied.
7.2 Effect of Termination. In the event of the ter-
mination of this Agreement pursuant to Section 7.1, this Agree-
ment, except for the provisions of the last sentence of Section
5.1(g) and the provisions of Sections 7.2 and 8.10, shall be-
come void and have no effect, without any liability on the part
of any party or its directors, officers or stockholders. Not-
withstanding the foregoing, nothing in this Section 7.2 shall
relieve any party to this Agreement of liability for a material
breach of any provision of this Agreement and provided, fur-
ther, however, that if it shall be judicially determined that
termination of this Agreement was caused by an intentional
breach of this Agreement, then, in addition to other remedies
at law or equity for breach of this Agreement, the party so
found to have intentionally breached this Agreement shall in-
demnify and hold harmless the other parties for their respec-
tive costs, fees and expenses of their counsel, accountants,
financial advisors and other experts and advisors as well as
fees and expense incident to negotiation, preparation and exe-
cution of this Agreement and related documentation and share-
holders' meetings and consents ("Costs") up to but not in ex-
cess of an amount equal to $2 million in the aggregate. If
this Agreement is terminated for any reason pursuant to Section
7.1 (other than a termination pursuant to Section 7.1(a),
7.1(b), 7.1(c) (other than a termination by Cardinal pursuant
to Section 7.1(c) if Pyxis's or Pyxis's affiliates failure to
perform any material covenant or obligation under this
-46-<PAGE>
Agreement has been the cause of or resulted in the failure of
the Merger to occur on or before June 30, 1996), 7.1(d), 7.1(g)
or 7.1(i)) Pyxis will, in the case of a termination by
Cardinal, within three business days following any such
termination or, in the case of a termination by Pyxis, prior to
such termination, pay to Cardinal in cash by wire transfer in
immediately available funds to an account designated by
Cardinal (i) in reimbursement for Cardinal's expenses an amount
in cash equal to the aggregate amount of Cardinal's Costs
incurred in connection with pursuing the transactions
contemplated by this Agreement, including, without limitation,
legal, accounting and investment banking fees, up to but not in
excess of an amount equal to $2 million in the aggregate and
(ii) a termination fee in an amount equal to $28 million. In
the event of the termination of this Agreement pursuant to
Section 7.1(i), Pyxis will within three business days following
any such termination pay to Cardinal in cash by wire transfer
in immediately available funds to an account designated by
Cardinal in reimbursement for Cardinal's expenses an amount in
cash equal to the aggregate amount of Cardinal's Costs incurred
in connection with pursuing the transactions contemplated by
this Agreement, including, without limitation, legal, account-
ing and investment banking fees, up to but not in excess of an
amount equal to $2 million in the aggregate.
7.3 Amendment. This Agreement may be amended by the
parties hereto, by action taken or authorized by their respec-
tive Boards of Directors, at any time before or after adoption
of this Agreement by Pyxis Stockholders or authorization of
issuance of Cardinal Common Shares in the Merger by Cardinal
Shareholders, but after each such approval or authorization, no
amendment shall be made which by law requires further approval
or authorization by the Pyxis Stockholders or Cardinal Share-
holders, as the case may be, without such further approval or
authorization. Notwithstanding the foregoing, this Agreement
may not be amended except by an instrument in writing signed on
behalf of each of the parties hereto.
7.4 Extension; Waiver. At any time prior to the
Effective Time, Cardinal (with respect to Pyxis) and Pyxis
(with respect to Cardinal and Subcorp) by action taken or au-
thorized by their respective Boards of Directors, may, to the
extent legally allowed, (a) extend the time for the performance
of any of the obligations or other acts of such party, (b)
waive any inaccuracies in the representations and warranties
contained herein or in any document delivered pursuant hereto
and (c) waive compliance with any of the agreements or condi-
tions contained herein. Any agreement on the part of a party
hereto to any such extension or waiver shall be valid only if
-47-<PAGE>
set forth in a written instrument signed on behalf of such
party.
ARTICLE VIII
MISCELLANEOUS
8.1 Survival of Representations and Warranties. The
representations and warranties made herein by the parties here-
to shall not survive the Effective Time. This Section 8.1
shall not limit any covenant or agreement of the parties here-
to, which by its terms contemplates performance after the Ef-
fective Time or the termination of this Agreement.
8.2 Notices. All notices and other communications
hereunder shall be in writing and shall be deemed given if de-
livered personally, telecopied (which is confirmed) or dis-
patched by a nationally recognized overnight courier service to
the parties at the following addresses (or at such other ad-
dress for a party as shall be specified by like notice):
(a) if to Cardinal or Subcorp:
Cardinal Health, Inc.
5555 Glendon Court
Dublin, Ohio 43016
Attention: Robert D. Walter
Telecopy No.: (614) 717-8919
with a copy to
David A. Katz
Wachtell, Lipton, Rosen & Katz
51 West 52nd Street
New York, New York 10019
Telecopy No.: (212) 403-2000
(b) if to Pyxis:
Pyxis Corporation
9380 Carroll Park Drive
San Diego, California 92121
Attention: Ronald R. Taylor
Telecopy No.: (619) 625-6684
with a copy to
Thomas E. Sparks, Jr.
-48-<PAGE>
Pillsbury Madison & Sutro LLP
235 Montgomery Street
San Francisco, California 94104
Telecopy No.: (415) 983-1200
8.3 Interpretation. When a reference is made in
this Agreement to an Article or Section, such reference shall
be to an Article or Section of this Agreement unless otherwise
indicated. The headings and the table of contents contained in
this Agreement are for reference purposes only and shall not
affect in any way the meaning or interpretation of this Agree-
ment. When a reference is made in this Agreement to Pyxis,
such reference shall be deemed to include any and all subsid-
iaries of Pyxis, individually and in the aggregate, except for
Sections 4.1, 4.2, 4.3, 4.4, 4.6, 4.8, 4.16, 4.24 and 4.30.
When a reference is made in this Agreement to Pyxis Common
Stock or shares thereof, such reference shall be deemed to
include the preferred share purchase rights issued pursuant to
the Rights Agreement that trade together with the Pyxis Common
Stock. For the purposes of any provision of this agreement, a
"material adverse effect" with respect to any party shall be
deemed to occur if the aggregate consequences of all breaches
and inaccuracies of covenants and representations of such party
under this Agreement, when read without any exception or quali-
fication for a material adverse effect, are reasonably likely
to have a material adverse effect on the assets, liabilities,
results of operations or financial condition of such party and
its subsidiaries taken as a whole.
8.4 Counterparts. This Agreement may be executed in
counterparts, which together shall constitute one and the same
Agreement. The parties may execute more than one copy of the
Agreement, each of which shall constitute an original.
8.5 Entire Agreement. This Agreement (including the
documents and the instruments referred to herein), the Support
Agreements, the Stock Option Agreement and the Confidentiality
Agreement constitute the entire agreement among the parties and
supersede all prior agreements and understandings, agreements
or representations by or among the parties, written and oral,
with respect to the subject matter hereof and thereof.
8.6 Third Party Beneficiaries. Nothing in this
Agreement, express or implied, is intended or shall be con-
strued to create any third party beneficiaries other than Sec-
tions 5.1(h) and 5.2(d).
8.7 Governing Law. This Agreement shall be governed
and construed in accordance with the laws of the State of Dela-
ware without regard to principles of conflicts of law.
-49-<PAGE>
8.8 Specific Performance. The transactions contem-
plated by this Agreement are unique. Accordingly, each of the
parties acknowledges and agrees that, in addition to all other
remedies to which it may be entitled, each of the parties here-
to is entitled to a decree of specific performance, provided
such party is not in material default hereunder.
8.9 Assignment. Neither this Agreement nor any of
the rights, interests or obligations hereunder shall be as-
signed by any of the parties hereto (whether by operation of
law or otherwise) without the prior written consent of the
other parties. Subject to the preceding sentence, this Agree-
ment shall be binding upon, inure to the benefit of and be en-
forceable by the parties and their respective successors and
assigns.
8.10 Expenses. Subject to the provisions of Section
7.2. and of the Stock Option Agreement, Cardinal and Pyxis
shall pay their own costs and expenses associated with the
transactions contemplated by this Agreement.
8.11 Pyxis Disclosure Schedule. Prior to the close
of business on February 8, 1996, Pyxis may supplement or amend
Sections 4.16, 4.17, 5.2(d) and/or 5.3(c) to the Pyxis
Disclosure Schedule or provide copies of any Contracts or
documents referenced thereon not provided to Cardinal prior to
the date of this Agreement. Cardinal shall, no later than the
close of business on February 9, 1996, notify Pyxis if Cardinal
has reasonably concluded that the inclusion in such Sections or
in such supplement or amendment of any Contracts, documents or
items could reasonably be deemed to adversely impact in any
material respect the benefits to be realized by Cardinal after
consummation of the Merger. Pyxis may at its option (subject
to Section 5.1(a) of this Agreement) terminate or amend, or
take such other action with respect to, the objectionable
Contracts, documents or items in such Sections, amendment or
supplement to the extent reasonably requested by Cardinal. To
the extent such objectionable Contracts, documents or items are
set forth in Sections 4.16 or 4.17 to the Pyxis Disclosure
Schedule or a supplement or amendment thereto and have not been
terminated, amended or otherwise dealt with to Cardinal's rea-
sonable satisfaction, the representations in Section 4.16 or
4.17 of this Agreement, as the case may be, shall be deemed to
be not true and correct in all material respects. To the
extent such objectionable Contracts, documents or items are set
forth in Section 5.2(d) or 5.3(c) to the Pyxis Disclosure
Schedule or a supplement or amendment thereto and have not been
terminated, amended or otherwise dealt with to Cardinal's rea-
sonable satisfaction, such Contracts, documents or items shall
be removed from Section 5.2(d) or 5.3(c) to the Pyxis
Disclosure Schedule, as the case may be.
-50-<PAGE>
IN WITNESS WHEREOF, Cardinal, Subcorp and Pyxis have
signed this Agreement as of the date first written above.
CARDINAL HEALTH, INC.
By: /s/ Robert D. Walter
Robert D. Walter
Chairman and CEO
AZTEC MERGER CORP.
By: /s/ Robert D. Walter
PYXIS CORPORATION
By: /s/ Ron Taylor
Ron Taylor
Chairman and CEO
-51-
STOCK OPTION AGREEMENT
STOCK OPTION AGREEMENT ("Option Agreement") dated
February 7, 1996, between CARDINAL HEALTH, INC. ("Cardinal"),
an Ohio corporation and PYXIS CORPORATION ("Pyxis"), a
Delaware corporation.
W I T N E S S E T H:
WHEREAS, the Board of Directors of Cardinal and the
Board of Directors of Pyxis have approved an Agreement and
Plan of Merger dated as of even date herewith (the "Merger
Agreement") providing for the merger of a wholly owned
subsidiary of Cardinal with and into Pyxis;
WHEREAS, as a condition and inducement to
Cardinal's willingness to enter into the Merger Agreement,
Cardinal has required that Pyxis agree, and Pyxis has agreed,
to grant to Cardinal the option set forth herein to purchase
authorized but unissued shares of Pyxis Common Stock;
NOW, THEREFORE, in consideration of the premises
herein contained, the parties agree as follows:
1. Definitions.
Capitalized terms used but not defined herein shall
have the same meanings as in the Merger Agreement.
2. Grant of Option.
Subject to the terms and conditions set forth
herein, Pyxis hereby grants to Cardinal an irrevocable option
(the "Option") to purchase up to 7,275,861 authorized and
unissued shares of Pyxis Common Stock at a price per share
(the "Purchase Price") equal to the lower of (x) $24.80 or
(y) the Exchange Ratio multiplied by the closing price of
Cardinal Common Shares as reported on the NYSE composite tape
on the last trading day immediately preceding the Notice Date
(as hereinafter defined), payable in cash as provided in
Section 4 hereof.
3. Exercise of Option.
(a) Cardinal may exercise the Option, in whole or
in part, at any time or from time to time if a Purchase Event
(as defined below) shall have occurred; provided, however,
that, to the extent the Option shall not have been previously
exercised, it shall terminate and be of no further force and<PAGE>
effect upon the earliest to occur of (i) the Effective Time
of the Merger and (ii) the termination of the Merger Agree-
ment (A) in accordance with Sections 7.1(a), 7.1(b), 7.1(c)
(other than a termination by Cardinal pursuant to Section
7.1(c) of the Merger Agreement if Pyxis's or Pyxis's
affiliate's failure to perform any material covenant or
obligation under the Merger Agreement has been the cause of
or resulted in the failure of the Merger to occur on or
before June 30, 1996), 7.1(d), 7.1(g) or 7.1(i) of the Merger
Agreement; provided further, however, if (x) the Merger
Agreement is terminated other than as provided in clause (ii)
above, or (y) the termination of the Merger Agreement (other
than a termination (I) pursuant to Sections 7.1(a), 7.1(c)
(other than a termination by Cardinal pursuant to Section
7.1(c) of the Merger Agreement if Pyxis's or Pyxis's
affiliate's failure to perform any material covenant or
obligation under the Merger Agreement has been the cause of
or resulted in the failure of the Merger to occur on or
before June 30, 1996), 7.1(g) or 7.1(i) or (II) by Aztec
pursuant to Section 7.1(d)) occurs after a Purchase Event,
the Option shall not terminate until the date that is 12
months following such termination. Notwithstanding the
foregoing, if the Option cannot be exercised before its date
of termination as a result of any injunction, order or simi-
lar restraint issued by a court of competent jurisdiction,
the Option shall expire on the 30th business day after such
injunction, order or restraint shall have been dissolved or
when such injunction, order or restraint shall have become
permanent and no longer subject to appeal, as the case may
be.
(b) As used herein, a "Purchase Event" shall mean
any of the following events:
(i) any person (other than Cardinal or any of its
subsidiaries) shall have commenced (as such term is
defined in Rule 14d-2 under the Securities Exchange Act
of 1934, as amended (the "Exchange Act")), or shall have
filed a registration statement under the Securities Act
of 1933, as amended (the "Securities Act"), with respect
to, a tender offer or exchange offer to purchase any
shares of Pyxis Common Stock such that, upon
consummation of such offer, such person would own or
control 10% or more of the then outstanding Pyxis Common
Stock;
(ii) Pyxis or any of its subsidiaries shall or
shall have entered into, authorized, recommended,
proposed or publicly announced an intention to enter
into, authorize, recommend, or propose, an agreement,
-2-<PAGE>
arrangement or understanding with any person (other than
Cardinal or any of its subsidiaries) to, or any person
(other than Cardinal or any of its subsidiaries) shall
have publicly announced a bona fide intention to, (A)
effect any Competing Transaction, (B) purchase, lease or
otherwise acquire 10% or more of the assets of Pyxis or
any of its subsidiaries or (C) purchase or otherwise
acquire (including by way of merger, consolidation,
tender or exchange offer or similar transaction) Benefi-
cial Ownership (as defined below) of securities repre-
senting 10% or more of the voting power of Pyxis or any
of its subsidiaries;
(iii) any person (other than Cardinal or any
subsidiary of Cardinal) shall have acquired Beneficial
Ownership or the right to acquire Beneficial Ownership
of 10% or more of the voting power of Pyxis;
(iv) Pyxis's Board of Directors shall have with-
drawn or modified in a manner adverse to Cardinal the
recommendation of Pyxis's Board of Directors with
respect to the Merger Agreement and/or the Merger;
(v) if at the meeting of Pyxis Stockholders
(including any adjournment or postponement thereof) the
requisite vote of the Pyxis Stockholders to approve the
Merger and the transactions contemplated by the Merger
Agreement shall not have been obtained; or
(vi) the Merger Agreement shall have been
terminated by either party pursuant to Section 7.1
thereof (other than a termination pursuant to Sections
7.1(a), 7.1(b), 7.1(c) (other than a termination by
Cardinal pursuant to Section 7.1(c) of the Merger
Agreement if Pyxis's or Pyxis's affiliate's failure to
perform any material covenant or obligation under the
Merger Agreement has been the cause of or resulted in
the failure of the Merger to occur on or before June 30,
1996), 7.1(d), 7.1(g) or 7.1(i)) or any event shall have
occurred that would cause any party thereto to have the
right to so terminate the Merger Agreement.
(c) As used herein, the terms "Beneficial Owner-
ship", "Beneficial Owner" and "Beneficially Own" shall have
the meanings ascribed to them in Rule 13d-3 under the Ex-
change Act. As used herein, "person" shall have the meaning
specified in Sections 3(a)(9) and 13(d)(3) of the Exchange
Act.
-3-<PAGE>
(d) In the event Cardinal wishes to exercise the
Option, it shall deliver to Pyxis a written notice (the date
of which being herein referred to as the "Notice Date")
specifying (i) the total number of shares it intends to pur-
chase pursuant to such exercise and (ii) a place and date not
earlier than two business days nor later than 60 calendar
days from the Notice Date for the closing of such purchase
(the "Closing Date"); provided that if the closing of the
purchase and sale pursuant to the Option (the "Closing")
cannot be consummated by reason of any applicable judgment,
decree, order, law or regulation, the period of time that
otherwise would run pursuant to this sentence shall run
instead from the date on which such restriction on
consummation has expired or been terminated; and, provided
further that, without limiting the foregoing, if prior
notification to or approval of any regulatory authority is
required in connection with such purchase, Cardinal and, if
applicable, Pyxis shall promptly file the required notice or
application for approval and shall expeditiously process the
same (and Pyxis shall cooperate with Cardinal in the filing
of any such notice or application and the obtaining of any
such approval), and the period of time that otherwise would
run pursuant to this sentence shall run instead from the date
on which, as the case may be, (i) any required notification
period has expired or been terminated or (ii) such approval
has been obtained, and in either event, any requisite waiting
period has passed.
(e) In the event (i) Cardinal receives official
notice that an approval of any regulatory authority required
for the purchase of Option Shares would not be issued or
granted or (ii) a Closing Date shall not have occurred within
18 months after the related Notice Date due to the failure to
obtain any such required approval, Cardinal shall be entitled
to exercise its right as set forth in Section 7 or, to the
extent legally permitted, to exercise the Option in
connection with the resale of Pyxis Common Stock or other
securities pursuant to a registration statement as provided
in Section 9. The provisions of this Section 3 and Section 6
shall apply with appropriate adjustments to any such
exercise.
4. Payment and Delivery of Certificates.
(a) At the Closing, referred to in Section 3
hereof, Cardinal shall pay to Pyxis the aggregate Purchase
Price for the shares of Pyxis Common Stock purchased pursuant
to the exercise of the Option in immediately available funds
by wire transfer to a bank account designated not later than
one business day prior to the Closing Date by Pyxis.
-4-<PAGE>
(b) At such closing, simultaneously with the de-
livery of cash as provided in Section 4(a), Pyxis shall de-
liver to Cardinal a certificate or certificates representing
the number of shares of Pyxis Common Stock purchased by
Cardinal, registered in the name of Cardinal or a nominee
designated in writing by Cardinal, which shares shall be
fully paid and non-assessable and free and clear of all
liens, claims, charges and encumbrances of any kind
whatsoever.
(c) If at the time of issuance of any Pyxis Common
Stock pursuant to any exercise of the Option, Pyxis shall
have issued any share purchase rights or similar securities
to holders of Pyxis Common Stock, then each such share of
Pyxis Common Stock shall also represent rights with terms
substantially the same as and at least as favorable to
Cardinal as those issued to other holders of Pyxis Common
Stock.
(d) Certificates for Pyxis Common Stock delivered
at any closing hereunder shall be endorsed with a restrictive
legend which shall read substantially as follows:
The shares represented by this certificate are
subject to certain provisions of an agreement
between the registered holder hereof and Pyxis
Corporation, a copy of which is on file at the
principal office of Pyxis Corporation, and to
resale restrictions arising under the Securities
Act of 1933, as amended, and any applicable state
securities laws. A copy of such agreement will be
provided to the holder hereof without charge upon
receipt by Pyxis Corporation of a written request
therefor.
It is understood and agreed that the above legend shall be
removed by delivery of substitute certificate(s) without such
legend if Cardinal shall have delivered to Pyxis an opinion
of counsel reasonably satisfactory to Pyxis to the effect
that such legend is not required for purposes of the
Securities Act and any applicable state securities laws.
5. Authorization, etc.
(a) Pyxis hereby represents and warrants to
Cardinal that:
-5-<PAGE>
(i) Pyxis has full corporate authority to execute
and deliver this Option Agreement and to consummate the
transactions contemplated hereby;
(ii) such execution, delivery and consummation have
been authorized by the Board of Directors of Pyxis, and
no other corporate proceedings are necessary therefor;
(iii) this Option Agreement has been duly and
validly executed and delivered and represents a valid
and legally binding obligation of Pyxis, enforceable
against Pyxis in accordance with its terms;
(iv) Pyxis has taken all necessary corporate action
to authorize and reserve and permit it to issue and, at
all times from the date hereof through the date of the
exercise in full or the expiration or termination of the
Option, shall have reserved for issuance upon exercise
of the Option, 7,275,861 shares of Pyxis Common Stock,
all of which, upon issuance pursuant hereto, shall be
duly authorized, validly issued, fully paid and
nonassessable, and shall be delivered free and clear of
all claims, liens, encumbrances, restrictions and
security interests and not subject to any preemptive
rights; and
(v) The Rights Agreement dated as of August 5,
1994, between Pyxis and First Interstate Bank (the
"Rights Agreement"), has been amended, and will remain
amended (and no replacement plan will be adopted), so as
to provide that none of Cardinal and its affiliates will
become an "Acquiring Person" and that no "Stock
Acquisition Date" or "Distribution Date" (as such terms
are defined in the Rights Agreement) will occur as a
result of the execution of this Option Agreement, the
grant of the Option hereunder or the acquisition or
transfer of shares of Pyxis Common Stock by Cardinal
pursuant to the exercise, in whole or in part, of the
Option.
(b) Pyxis hereby agrees that, prior to the
termination of the Option pursuant to Section 3(a) hereof,
Pyxis shall not take, or allow to be taken, any action that
could result in the representations and warranties set forth
in Section 5(a)(v) hereof becoming false or inaccurate.
(c) Cardinal hereby represents and warrants to
Pyxis that:
-6-<PAGE>
(i) Cardinal has full corporate authority to ex-
ecute and deliver this Option Agreement and to consum-
mate the transactions contemplated hereby;
(ii) such execution, delivery and consummation have
been authorized by all requisite corporate action by
Cardinal, and no other corporate proceedings are neces-
sary therefor;
(iii) this Option Agreement has been duly and
validly executed and delivered and represents a valid
and legally binding obligation of Cardinal, enforceable
against Cardinal in accordance with its terms; and
(iv) any Pyxis Common Stock or other securities ac-
quired by Cardinal upon exercise of the Option will not
be taken with a view to the public distribution thereof
and will not be transferred or otherwise disposed of ex-
cept in compliance with the Securities Act.
6. Adjustment upon Changes in Capitalization.
(a) In the event of any change in Pyxis Common
Stock by reason of a stock dividend, split-up,
recapitalization, combination, exchange of shares or similar
transaction, the type and number of shares or securities
subject to the Option, and the Purchase Price therefor, shall
be adjusted appropriately, and proper provision shall be made
in the agreements governing such transaction, so that
Cardinal shall receive upon exercise of the Option the same
class and number of outstanding shares or other securities or
property that Cardinal would have received in respect of
Pyxis Common Stock if the Option had been exercised
immediately prior to such event, or the record date therefor,
as applicable. If any additional shares of Pyxis Common
Stock are issued after the date of this Option Agreement
(other than pursuant to an event described in the first
sentence of this Section 6(a) or pursuant to this Option
Agreement) the number of shares of Pyxis Common Stock subject
to the Option shall be adjusted so that, after such issuance,
it equals 19.9% of the number of shares of Pyxis Common Stock
then issued and outstanding, without giving effect to any
shares subject to or issued pursuant to the Option.
(b) In the event that Pyxis shall enter into an
agreement (i) to consolidate with or merge into any person,
other than Cardinal or one of its subsidiaries, and shall not
be the continuing or surviving corporation of such
consolidation or merger, (ii) to permit any person, other
than Cardinal or one of its subsidiaries, to merge into Pyxis
-7-<PAGE>
and Pyxis shall be the continuing or surviving corporation,
but, in connection with such merger, the then outstanding
shares of Pyxis Common Stock shall be changed into or
exchanged for stock or other securities of Pyxis or any other
person or cash or any other property or the shares of Pyxis
Common Stock outstanding immediately before such merger shall
after such merger represent less than 50% of the outstanding
common shares and common share equivalents of Pyxis, or (iii)
to sell or otherwise transfer all or substantially all of its
assets to any person, other than Cardinal or one of its
subsidiaries, then, and in each such case, the agreement
governing such transaction shall make proper provisions so
that the Option shall, upon the consummation of any such
transaction and upon the terms and conditions set forth
herein, be converted into, or exchanged for, an option, at
the election of Cardinal, with respect to any of the
following persons (as designated by Cardinal) (I) the
Acquiring Corporation (as defined below), (II) any person
that controls the Acquiring Corporation, or (III) in the case
of a merger described in clause (ii), Pyxis.
(c) For purposes hereof, "Acquiring Corporation"
means (i) the continuing or surviving corporation of a
consolidation or merger with Pyxis (if other than Pyxis),
(ii) Pyxis in a merger in which Pyxis is the continuing or
surviving corporation and (ii) the transferee of all or
substantially all of Pyxis's assets. The provisions of
Sections 7, 8, 9 and 10 shall apply with appropriate
adjustments to any securities for which the Option becomes
exercisable pursuant to this Section 6.
7. Repurchase.
(a) At the request of Cardinal at any time
commencing upon the occurrence of a Purchase Event and ending
13 months immediately thereafter (the "Cardinal Repurchase
Period"), Pyxis (or any successor entity thereof) shall
repurchase the Option from Cardinal together with all (but
not less than all) shares of Pyxis Common Stock purchased by
Cardinal pursuant thereto with respect to which Cardinal then
has Beneficial Ownership, at a price (when calculated on a
per share basis, the "Per Share Repurchase Price") equal to
the sum of:
(i) The difference between (A) the "Market/Tender
Offer Price" for shares of Pyxis Common Stock (defined
as the higher of (x) the highest price per share at
which a tender or exchange offer has been made for
shares of Pyxis Common Stock or (y) the highest closing
mean of the "bid" and the "ask" price per share of Pyxis
-8-<PAGE>
Common Stock reported by the Nasdaq National Market, the
automated quotation system of the National Association
of Securities Dealers, Inc., for any day within that
portion of the Cardinal Repurchase Period which precedes
the date Cardinal gives notice of the required
repurchase under this Section 7) and (B) the exercise
price as determined pursuant to Section 2 hereof
(subject to adjustment as provided in Section 6), mul-
tiplied by the number of shares of Pyxis Common Stock
with respect to which the Option has not been exercised,
but only if such Market/Tender Offer Price is greater
than such exercise price;
(ii) The exercise price paid by Cardinal for any
shares of Pyxis Common Stock acquired pursuant to the
Option;
(iii) The difference between the Market/Tender
Offer Price and the exercise price paid by Cardinal for
any shares of Pyxis Common Stock purchased pursuant to
the exercise of the Option, multiplied by the number of
shares so purchased, but only if such Market/Tender
Offer Price is greater than such exercise price; and
(iv) Cardinal's out-of-pocket expenses incurred in
connection with pursuing the transactions contemplated
by the Merger Agreement, including, without limitation,
legal, accounting and investment banking fees, up to but
not in excess of an amount equal to $2 million in the
aggregate, less any amounts previously paid by Pyxis to
Cardinal solely in reimbursement for Costs pursuant to
Section 7.2 of the Merger Agreement.
(b) In the event Cardinal exercises its rights un-
der this Section 7, Pyxis shall, within 10 business days
thereafter, pay the required amount to Cardinal by wire
transfer of immediately available funds to an account
designated by Cardinal and Cardinal shall surrender to Pyxis
the Option and the certificates evidencing the shares of
Pyxis Common Stock purchased thereunder with respect to which
Cardinal then has Beneficial Ownership.
(c) In determining the Market/Tender Offer Price,
the value of any consideration other than cash shall be de-
termined by an independent nationally recognized investment
banking firm selected by Cardinal and reasonably acceptable
to Pyxis.
-9-<PAGE>
8. Repurchase at Option of Pyxis
Except to the extent that Cardinal shall have
previously exercised its rights under Section 7, at the re-
quest of Pyxis during the six-month period commencing 13
months following the first occurrence of a Purchase Event,
Pyxis may repurchase from Cardinal, and Cardinal shall sell
to Pyxis, all (but not less than all) of the Pyxis Common
Stock acquired by Cardinal pursuant to the Option and with
respect to which Cardinal has Beneficial Ownership at the
time of such repurchase at a price per share equal to the
greater of (i) 110% of the Market/Tender Offer Price per
share (calculated in the manner set forth in Section 7(a)(i)
hereof but utilizing the period beginning on the occurrence
of a Purchase Event and ending on the date Pyxis exercises
its repurchase right pursuant to this Section 8), (ii) the
Per Share Repurchase Price or (iii) the sum of (A) the
aggregate Purchase Price of the shares so repurchased plus
(B) interest on the aggregate Purchase Price paid for the
shares so repurchased from the date of purchase by Cardinal
to the date of repurchase at the highest rate of interest an-
nounced by Bank One, Columbus, NA as its prime or base
lending or reference rate during such period, less any
dividends received on the shares so repurchased, plus (C)
Cardinal's out-of-pocket expenses incurred in connection with
pursuing the transactions contemplated by the Merger
Agreement, including, without limitation, legal, accounting
and investment banking fees, less any amounts previously paid
by Pyxis to Cardinal solely in reimbursement for Costs
pursuant to Section 7.2(i) of the Merger Agreement, which sum
shall be divided by the number of shares of Pyxis Common
Stock to be repurchased by Pyxis. Any repurchase under this
Section 8 shall be consummated in accordance with Section
7(b).
9. Registration Rights.
At any time after a Purchase Event, Pyxis shall, if
requested by any holder or Beneficial Owner of shares of
Pyxis Common Stock issued upon exercise of the Option (each a
"Holder"), as expeditiously as possible file a registration
statement on a form for general use under the Securities Act
if necessary in order to permit the sale or other disposition
of the shares of Pyxis Common Stock that have been acquired
upon exercise of the Option in accordance with the intended
method of sale or other disposition requested by any such
Holder. Each such Holder shall provide all information
reasonably requested by Pyxis for inclusion in any
registration statement to be filed hereunder. Pyxis shall
use its best efforts to cause such registration statement
-10-<PAGE>
first to become effective and then to remain effective for
such period not in excess of 180 days from the day such
registration statement first becomes effective as may be
reasonably necessary to effect such sales or other disposi-
tions. The registration effected under this Section 9 shall
be at Pyxis's expense except for underwriting commissions and
the fees and disbursements of such Holders' counsel at-
tributable to the registration of such Pyxis Common Stock.
In no event shall Pyxis be required to effect more than two
registrations hereunder. The filing of any registration
statement required hereunder may be delayed for such period
of time (not to exceed 60 days) as may reasonably be required
to facilitate any public distribution by Pyxis of Pyxis
Common Stock or if a special audit of Pyxis would otherwise
be required in connection therewith. If requested by any
such Holder in connection with such registration, Pyxis shall
become a party to any underwriting agreement relating to the
sale of such shares on terms and including obligations and
indemnities which are customary for parties similarly
situated. Upon receiving any request for registration under
this Section 9 from any Holder, Pyxis agrees to send a copy
thereof to any other person known to Pyxis to be entitled to
registration rights under this Section 9, in each case by
promptly mailing the same, postage prepaid, to the address of
record of the persons entitled to receive such copies.
10. Listing.
If Pyxis Common Stock or any other securities to be
acquired upon exercise of the Option are then listed on the
Nasdaq National Market or any national securities exchange,
Pyxis, upon the request of Cardinal, will promptly file an
application to list the shares of Pyxis Common Stock or other
securities to be acquired upon exercise of the Option on the
Nasdaq National Market or such exchange and will use its best
efforts to obtain approval of such listings as soon as
practicable.
11. Severability.
Any term, provision, covenant or restriction con-
tained in this Option Agreement held by a court or other
Governmental Authority of competent jurisdiction to be
invalid, void or unenforceable, shall be ineffective to the
extent of such invalidity, voidness or unenforceability, but
neither the remaining terms, provisions, covenants or
restrictions contained in this Option Agreement nor the
validity or enforceability thereof in any other jurisdiction
shall be affected or impaired thereby. Any term, provision,
covenant or restriction contained in this Option Agreement
-11-<PAGE>
that is so found to be so broad as to be unenforceable shall
be interpreted to be as broad as is enforceable.
12. Miscellaneous.
(a) Expenses. Each of the parties hereto shall
pay all costs and expenses incurred by it or on its behalf in
connection with the transactions contemplated hereunder, in-
cluding fees and expenses of its own financial consultants,
investment bankers, accountants and counsel, except as other-
wise provided herein.
(b) Entire Agreement. This Agreement, the Support
Agreements, the Merger Agreement (including the documents and
the instruments referred to therein) and the Confidentiality
Agreement constitute the entire agreement among the parties
and supersede all prior agreements and understandings,
agreements or representations by or among the parties,
written and oral, with respect to the subject matter hereof
and thereof.
(c) Successors; No Third Party Beneficiaries. The
terms and conditions of this Option Agreement shall inure to
the benefit of and be binding upon the parties hereto and
their respective successors and permitted assigns. Nothing
in this Option Agreement, expressed or implied, is intended
to confer upon any party, other than the parties hereto, and
their respective successors and assigns, any rights, reme-
dies, obligations, or liabilities under or by reason of this
Option Agreement, except as expressly provided herein.
(d) Notices. All notices or other communications
which are required or permitted hereunder shall be in writing
and sufficient if delivered in accordance with Section 8.2 of
the Merger Agreement (which is incorporated herein by ref-
erence).
(e) Counterparts. This Option Agreement may be
executed in counterparts, and each such counterpart shall be
deemed to be an original instrument, but both such counter-
parts together shall constitute but one agreement.
(f) Further Assurances. In the event of any
exercise of the Option by Cardinal, Pyxis and Cardinal shall
execute and deliver all other documents and instruments and
take all other action that may be reasonably necessary in
order to consummate the transactions provided for by such
exercise.
-12-<PAGE>
(g) Specific Performance. The parties hereto
agree that if for any reason Cardinal or Pyxis shall have
failed to perform its obligations under this Option Agree-
ment, then either party hereto seeking to enforce this Option
Agreement against such non-performing party shall be entitled
to specific performance and injunctive and other equitable
relief, and the parties hereto further agree to waive any re-
quirement for the securing or posting of any bond in connec-
tion with the obtaining of any such injunctive or other equi-
table relief. This provision is without prejudice to any
other rights that either party hereto may have against the
other party hereto for any failure to perform its obligations
under this Option Agreement.
(h) Governing Law. This Option Agreement shall be
governed by and construed in accordance with the laws of the
State of Delaware applicable to agreements made and entirely
to be performed within such state. Nothing in this Option
Agreement shall be construed to require any party (or any
subsidiary or affiliate of any party) to take any action or
fail to take any action in violation of applicable law, rule
or regulation.
(i) Regulatory Approvals; Section 16(b). If, in
connection with the exercise of the Option under Section 3,
prior notification to or approval of any Governmental
Authority is required, then the required notice or applica-
tion for approval shall be promptly filed and/or expedi-
tiously processed by Pyxis and periods of time that otherwise
would run pursuant hereto (if any) shall run instead from the
date on which any such required notification period has
expired or been terminated or such approval has been
obtained, and in either event, any requisite waiting period
shall have passed. Periods of time that otherwise would run
pursuant to Sections 3, 7 or 8 shall also be extended to the
extent necessary to avoid liability under Section 16(b) of
the Exchange Act.
(j) Waiver and Amendment. Any provision of this
Agreement may be waived at any time by the party that is en-
titled to the benefits of such provision. This Option Agree-
ment may not be modified, amended, altered or supplemented
except upon the execution and delivery of a written agreement
executed by the parties hereto.
-13-<PAGE>
IN WITNESS WHEREOF, each of the parties hereto has
executed this Option Agreement as of the date first written
above.
CARDINAL HEALTH, INC.
By: /s/ Robert D. Walter
Name: Robert D. Walter
Title: Chairman and CEO
PYXIS CORPORATION
By: /s/ Ron Taylor
Name: Ron Taylor
Title: Chairman and CEO
-14-
[Form of Support/Voting Agreement]
February 7, 1996
Cardinal Health, Inc.
5555 Glendon Court
Dublin, Ohio 43016
Re: Support/Voting Agreement
Dear Sirs:
The undersigned understands that Cardinal Health,
Inc. ("Cardinal"), Aztec Merger Corp., a wholly owned subsid-
iary of Cardinal ("Subcorp"), and Pyxis Corporation ("Pyxis")
are entering into an Agreement and Plan of Merger dated the
date hereof (the "Agreement") providing for, among other
things, a merger between Subcorp and Pyxis (the "Merger"), in
which all of the outstanding shares of capital stock of Pyxis
will be exchanged for shares of common stock, without par
value, of Cardinal.
The undersigned is a stockholder of Pyxis (the
"Stockholder") and is entering into this letter agreement to
induce you to enter into the Agreement and to consummate the
transactions contemplated thereby.
The Stockholder confirms its agreement with you as
follows:
1. The Stockholder represents, warrants and agrees
that Schedule I annexed hereto sets forth the shares of the
capital stock of Pyxis of which the Stockholder or its
affiliates (as defined under the Securities Exchange Act of
1934, as amended) is the record or beneficial owner (the
"Shares") and that the Stockholder and its affiliates are on
the date hereof the lawful owners of the number of Shares set
forth in Schedule I, free and clear of all liens, charges,
encumbrances, voting agreements and commitments of every
kind, except as disclosed in Schedule I. Except as set forth
in Schedule I, neither the Stockholder nor any of its
affiliates own or hold any rights to acquire any additional
shares of the capital stock of Pyxis (by exercise of stock
options or otherwise) or any interest therein or any voting
rights with respect to any additional shares.
2. The Stockholder agrees that it will not, will
not permit any company, trust or other entity controlled by
the Stockholder to, and will not permit any of its affiliates<PAGE>
to, contract to sell, sell or otherwise transfer or dispose
of any of the Shares or any interest therein or securities
convertible thereinto or any voting rights with respect
thereto, other than (i) pursuant to the Merger or (ii) with
your prior written consent.
3. The Stockholder agrees to, will cause any
company, trust or other entity controlled by the Stockholder
to, and will cause its affiliates to, cooperate fully with
you in connection with the Agreement and the transactions
contemplated thereby. The Stockholder agrees that it will
not, will not permit any such company, trust or other entity
to, and will not permit any of its affiliates to, directly or
indirectly (including through its officers, directors,
employees or other representatives) to solicit, initiate, en-
courage or facilitate, or furnish or disclose non-public
information in furtherance of, any inquiries or the making of
any proposal with respect to any recapitalization, merger,
consolidation or other business combination involving Pyxis,
or acquisition of any capital stock or any material portion
of the assets (except for acquisition of assets in the ordi-
nary course of business consistent with past practice) of
Pyxis, or any combination of the foregoing (a "Competing
Transaction"), or negotiate, explore or otherwise engage in
discussions with any person (other than Cardinal, Subcorp or
their respective directors, officers, employees, agents and
representatives) with respect to any Competing Transaction or
enter into any agreement, arrangement or understanding with
respect to any Competing Transaction or agree to or otherwise
assist in the effectuation of any Competing Transaction;
provided, however, that nothing herein shall prevent the
Stockholder from taking any action or omitting to take any
action (i) as a member of the Board of Directors of Pyxis
necessary so as not to violate such Stockholder's fiduciary
obligations as a Director or (ii) as an officer of Pyxis at
the direction or request of the Board of Directors of Pyxis
so long as such direction or request was not made in
violation of any of the terms of the Agreement.
4. The Stockholder agrees that all of the Shares
beneficially owned by the Stockholder or its affiliates, or
over which the Stockholder or any of its affiliates has
voting power or control, directly or indirectly (including
any common shares of Pyxis acquired after the date hereof),
at the record date for any meeting of stockholders of Pyxis
called to consider and vote to approve the Merger and the
Agreement and/or the transactions contemplated thereby will
be voted by the Stockholder or its affiliates in favor
-2-<PAGE>
thereof and that neither Stockholder nor any of its
affiliates will vote such Shares in favor of any Competing
Transaction.
5. The Stockholder has all necessary power and au-
thority to enter into this letter agreement. This agreement
is the legal, valid and binding agreement of the Stockholder,
and is enforceable against the Stockholder in accordance with
its terms.
6. The Stockholder agrees that damages are an in-
adequate remedy for the breach by Stockholder of any term or
condition of this letter agreement and that you shall be en-
titled to a temporary restraining order and preliminary and
permanent injunctive relief in order to enforce our agree-
ments herein.
-3-<PAGE>
This letter agreement may be terminated at the op-
tion of any party at any time after the earlier of (i) ter-
mination of the Agreement and (ii) the Effective Time (as
defined in the Agreement). Please confirm that the foregoing
correctly states the understanding between us by signing and
returning to me a counterpart hereof.
Very truly yours,
By: _______________________
Stockholder
Confirmed on the date
first above written.
Cardinal Health, Inc.
By: ___________________________
-4-<PAGE>
Schedule I
Stock Ownership
of
Owned Beneficially (including Stock Options)
Owned of Record
